FEDERAL COURT OF AUSTRALIA

McCallum, in the Matter of Re Holdco Pty Ltd (Administrators Appointed) (No 2) [2021] FCA 377

ORDERS

THE COURT ORDERS THAT:

1.    The claim made by the plaintiffs in respect of items 11 and 12 of the plaintiffs' amended notice of claim is dismissed.

2.    The claim made by the first interested party (Westpac) in the proceeding is upheld to the extent determined in the accompanying reasons of the Court, namely that Westpac is entitled to a proportionate share of the balance of the Retained Proceeds (after payment of all other amounts pursuant to previous orders of the Court) of 65.5%.

3.    The claim made by the second and third interested parties (Sargon Capital and Taiping) in the proceeding is upheld to the extent determined in the accompanying reasons of the Court, namely that Sargon Capital is entitled to a proportionate share of the balance of the Retained Proceeds (after payment of all other amounts pursuant to previous orders of the Court) of 13.1%.

4.    The claims made by the fourth interested party (GrowthOps) and the fifth and sixth interested parties (Diversa and OneVue) in the proceeding are dismissed.

5.    The plaintiffs, Westpac, and Sargon Capital and Taiping have liberty to apply to the Court for:

(a)    a final order that gives effect to orders 1 to 4 herein by specifying the dollar amounts to be paid to each of them from the Retained Proceeds;

(b)    any other order consequential upon the accompanying reasons of the Court.

6.    By 19 May 2021, any party (costs applicant) that seeks an order for the payment of the whole or part of its costs of the proceeding by another party (costs respondent) is to file and serve any evidence relied on and a written submission of no more than 5 pages which specifies the amount claimed in a lump sum.

7.    By 16 June 2021, any costs respondent is to file and serve any evidence relied on and a written submission of no more than 5 pages in response.

8.    Subject to further order, any costs awarded in the proceeding will be awarded in a lump sum pursuant to rule 40.02(b) of the Federal Court Rules 2011 (Cth).

9.    The Court will determine the award of costs on the papers unless any party gives notice in its written submission that it seeks a hearing on the question of costs.

Note:    Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

SCHEDULE OF INTERESTED PARTIES

REASONS FOR JUDGMENT

O’BRYAN J:

A.    INTRODUCTION

1    The Sargon Group was a corporate group consisting of approximately 39 companies which conducted a series of financial planning, corporate trustee, responsible entity, superannuation and related financial services businesses. Sargon Capital Pty Ltd (Receivers and Managers Appointed) (In Liquidation) ACN 608 799 873 (Sargon Capital) was at all relevant times the ultimate holding company of the Sargon Group. The corporate structure of the Sargon Group as at 4 May 2020, as relevant to these proceedings, is set out in Appendix A to these reasons (which has been extracted from Annexure A to the Joint Statement of Agreed Facts tendered by the parties and which is reproduced below).

2    External administration of Sargon Group entities commenced on 29 January 2020 with the appointment of Mr Shaun Fraser and Mr Jason Preston of McGrathNicol as joint and several receivers and managers of Sargon Capital by secured creditor Taiping Trustees Limited (Taiping). Subsequently, on 8 March 2020, Joseph Hayes and Andrew McCabe of Wexted Advisors were appointed to act as administrators of Sargon Capital pursuant to s 436C of the Corporations Act 2001 (Cth) (Corporations Act) and, on 8 April 2020, Messrs Hayes and McCabe were appointed joint and several liquidators of Sargon Capital.

3    The plaintiffs in this proceeding, Stewart McCallum and Adam Nikitins of Ernst & Young, were appointed as joint and several voluntary administrators of the following Sargon Group entities on 4 February 2020:

(a)    Re Holdco Pty Ltd ACN 612 592 471 (Re Holdco);

(b)    RSE Holdco Pty Ltd ACN 612 586 893 (RSE Holdco);

(c)    Sargon Services Pty Ltd ACN 163 522 058 (Sargon Services);

(d)    Sargon CT Holdings Pty Ltd ACN 628 621 321 (Sargon CT Holdings);

(e)    SC International Holdings 2 Pty Ltd ACN 630 632 343 (SCIH2);

(f)    Sargon Superannuation Holdings Pty Ltd ACN 630 648 225 (Sargon SH); and

(g)    Sargon Superannuation Holdings SPV Pty Ltd ACN 633 509 494 (Sargon SPV),

(which I will refer to collectively as the Sargon VA Entities).

4    The plaintiffs were also appointed as joint and several voluntary administrators of SC Australian Holdings 1 Pty Ltd (SCAH1). However, on 4 February 2020, Mr Daniel Walley and Mr Christopher Hill of PricewaterhouseCoopers were appointed as joint and several receivers and managers of SCAH1. As a result, the plaintiffs did not seek to deal with SCAH1 and it is not directly relevant to this proceeding.

5    Subsequently, on 14 May 2020, the plaintiffs were appointed as liquidators of the Sargon VA Entities.

6    Between the date of their appointment as administrators and the end of April 2020, the plaintiffs negotiated a sale of certain of the businesses and assets of the Sargon VA Entities to the Cloverhill Group (Cloverhill Sale). The sale was complicated by disputes over the ownership of, and security interests held over, certain of the assets to be sold. As a result of those disputes, on 30 April 2020 the plaintiffs sought urgent relief from the Court under ss 442C and 447A of the Corporations Act. Specifically, under s 442C(2)(c), the plaintiffs sought leave of the Court to dispose of:

(a)    all intellectual property used or in the possession of Sargon Services (including, but not limited to, intellectual property in relation to the software systems known as "Arcadia", "Sentinel", "Metropolis", "API Impact" and "Sargon Pay", and in relation to the trademarks and domain names set out in the annexure to the originating process); and

(b)    such property of the Sargon VA Entities as is (or may be) subject to a security interest (including under the Personal Property Securities Act 2009 (Cth)),

in connection with, and as part of, the sale of the property of the Sargon VA Entities pursuant to the Cloverhill Sale. The plaintiffs also sought orders as to the treatment of the proceeds of the sale for the purposes of satisfying the requirement in s 442C(3) to make arrangements for the adequate protection of the interests of the owners of the intellectual property and the security interest holders. Under s 447A of the Corporations Act, the plaintiffs sought orders as to how Part 5.3A of the Corporations Act was to operate in relation to the proceeds of sale so as to preserve the rights of the owners of the intellectual property and the security interest holders as between themselves.

7    On 1 May 2020, I made orders under ss 442C and 447A to facilitate the Cloverhill Sale as sought by the plaintiffs. On 19 May 2020, I published reasons for making those orders: McCallum, in the Matter of Re Holdco Pty Ltd (Administrators Appointed) [2020] FCA 666; 145 ACSR 243 (Re Holdco).

8    One of the orders made at that time was an order that, upon the completion of the Cloverhill Sale, all proceeds of the Cloverhill Sale (excluding the sum of $400,000 representing consideration for the sale of ancillary assets belonging to the "Decimal Entities") (Retained Proceeds) were to be deposited into a separate controlled, interest-bearing monies account to be maintained by the plaintiffs and which could only be accessed or disbursed by the plaintiffs in accordance with an order or direction of the Court. The Retained Proceeds were to be retained for the purpose of meeting claims that any party had in respect of the property of the Sargon VA Entities directly or indirectly sold pursuant to the Cloverhill Sale including (but not limited to):

(a)    any claim by the plaintiffs to recover from the Retained Proceeds amounts in respect of remuneration, fees and expenses properly incurred in their capacity as voluntary administrators of the Sargon VA Entities;

(b)    claims of the first interested party, Westpac Banking Corporation (Westpac), including its rights under security interests registered on the Personal Property Securities Register prior to completion of the Cloverhill Sale;

(c)    any claim that the second and third interested parties, Sargon Capital and Taiping, and/or the fourth interested party, GrowthOps Services Pty Ltd (GrowthOps), may have to recover from the Retained Proceeds amounts by reference to a claimed interest in, or in respect of, the intellectual property that was sold; and

(d)    any claim that the fifth and sixth interested parties, Diversa Pty Ltd (Diversa) and its parent company OneVue Holdings Limited (OneVue), may have pursuant to any equitable lien or other security interest over the shares held by Sargon SH and Sargon SPV in Diversa Trustees Limited ACN 006 421 638 (DTL) and CCSL Limited ACN 104 967 964 (CCSL).

9    This proceeding concerns the resolution of the above claims. The task being undertaken by the Court is a task required by the orders made on 1 May 2020 pursuant to s 442C of the Corporations Act, which is to apply the Retained Proceeds for the purpose of meeting claims that any party has as owners of, or security holders in, the property that was sold. In meeting claims, the Court is carrying into effect the requirement of s 442C(3) to protect adequately the interests of such parties (to the extent the Court has found that they are owners or security holders in respect of the property that was sold).

10    The method of apportioning the sale proceeds across the various claims of the plaintiffs and interested parties was described in Re Holdco as follows (at [67]):

Under the proposed arrangements, the retained sale proceeds would not simply be apportioned across claimants according to the amount of their respective claims. Rather, the retained proceeds would be apportioned across the different asset classes in respect of which parties claim interests by reference to the relative value of each asset class to the sale proceeds. Once that allocation has been done, all persons who have claims in respect of each asset class will have that claim determined and receive their entitlement to the apportioned sale proceeds. The properly incurred expenses of the administrators will be deducted rateably across the asset classes, and the reasonableness of the expenses will also need to be established.

11    In this proceeding, no party sought to contradict or vary that method of apportioning the sale proceeds. The relative values of different asset classes will ultimately be expressed as a percentage, so that the monetary entitlements of successful claimants can be calculated by applying the relevant percentage to the balance of the Retained Proceeds after deducting the plaintiffs’ properly incurred expenses. The parties agreed that that method would give effect to the requirement stipulated in s 442C(3) to protect adequately the interests of each secured party. The dispute between the interested parties concerned the existence of ownership or security interests in different asset classes and the method by which the relative value of different asset classes should be determined.

12    The Cloverhill Sale was effected by the execution of a Business Sale Agreement dated 4 May 2020 (Business Sale Agreement) and separate Share Sale Agreements dated 4 May 2020 for the sale of all the shares in the following subsidiaries of the Sargon VA Entities:

(a)    Responsible Entity Partners Ltd (REP);

(b)    Tidswell Financial Services Ltd (Tidswell);

(c)    Mammatus Pty Ltd (Mammatus);

(d)    Sargon CT Pty Ltd (Sargon CT);

(e)    Sargon CT (NSW) Pty Ltd (Sargon CT NSW);

(f)    Sargon Limited (NZ) (Sargon NZ);

(g)    CCSL; and

(h)    DTL,

(which I will refer to collectively as the Sale Subsidiaries).

13    The purchasers were Pacific Infrastructure Services Pty Ltd and Pacific Infrastructure Holdings Pty Ltd (collectively, Pacific Infrastructure). The overall total consideration for the Cloverhill Sale (paid pursuant to the Business Sale Agreement and the Share Sale Agreements) was $29,600,000 (being the $30,000,000 gross proceeds less $400,000 payable to the Decimal entities).

14    On 15 May 2020, the plaintiffs and each of the interested parties filed and served notices of their claims to the Retained Proceeds in accordance with the orders of the Court made on 1 May 2020. On 18 December 2020 (as an annexure to their written submissions), the plaintiffs served an amended notice of claim.

15    In accordance with the orders made on 1 May 2020, various deductions have been made from the Retained Proceeds from time to time, including:

(a)    $351,884 paid to the Australian Taxation Office pursuant to orders dated 4 August 2020;

(b)    $19,470 paid to the mediator for conducting the mediation of the proceeding pursuant to orders dated 4 August 2020;

(c)    $120,653.25 paid to the Victorian and New South Wales State Revenue Offices pursuant to orders dated 15 September 2020; and

(d)    $38,219.79 paid to Intralinks, Inc pursuant to orders dated 16 December 2020;

(e)    $14,492.84 paid to Gilbert + Tobin, solicitors to the plaintiffs, on account of disbursements pursuant to orders dated 16 March 2021;

(f)    $8,205.00 paid to the Federal Court of Australia on account of setting down and hearing fees pursuant to orders dated 16 March 2021; and

(g)    $3,625.57 paid to Gilbert + Tobin, solicitors to the plaintiffs, on account of disbursements pursuant to orders dated 19 April 2021.

16    On 27 August 2020, the plaintiffs filed an interlocutory application under paragraph 60-10(1)(c) of the Insolvency Practice Schedule (Corporations) (being Schedule 2 to the Corporations Act) seeking determination of the remuneration that the plaintiffs are entitled to receive for work performed in the voluntary administrations and liquidations of the Sargon VA Entities. That application was referred to a Registrar of the Federal Court for determination.

17    On 20 January 2021, I made an order by consent concerning the plaintiffs’ notice of claim in this proceeding, which resolved almost the entirety of the plaintiffs’ claim (other than items 11 and 12 of the plaintiffs' amended notice of claim). That order was as follows:

The following amounts may be withdrawn by the Plaintiffs from the Retained Proceeds (as defined in the orders made in this proceeding on 1 May 2020 (1 May 2020 Orders)) and applied in full and final satisfaction of any claim by the Plaintiffs to the Retained Proceeds for reimbursement of the Plaintiffs’ remuneration, costs and expenses including counsel fees (excluding any other costs and expenses, including counsel fees, of the Plaintiffs as agreed between the parties by consent or as approved by order of the Court to be paid from the Retained Proceeds):

(a)     such amount, up to a maximum of $1,259,721.80, as is determined by the Federal Court of Australia pursuant to the interlocutory process filed by the Plaintiffs on 27 August 2020 on account of the Plaintiffs’ remuneration incurred in the voluntary administrations and liquidations of the Sargon VA Entities (as defined in the 1 May 2020 Orders);

(b)     the amount of $336,904.70 on account of the remuneration incurred in connection with the voluntary administration of Sargon Services Pty Ltd (In Liquidation) as approved by the creditors at the reconvened second meeting of creditors on 14 May 2020 (Reconvened Second Meeting);

(c)     the amount of $536,825.69 on account of the remuneration incurred in connection with the voluntary administration of Sargon CT Holdings Pty Ltd (In Liquidation) as approved by the creditors at the Reconvened Second Meeting; and

(d)     the amount of $2,653,570.97 on account of the Plaintiffs’ reasonable costs and expenses incurred in the voluntary administrations and liquidations of the Sargon VA Entities.

18    The above consent order gives priority to the majority of the plaintiffs’ claim out of the Retained Proceeds. As stated above, after deducting the plaintiffs’ claim, the balance of the Retained Proceeds will be apportioned between the interested parties which are able to establish a claim to particular asset classes (by reason of an ownership or security interest) by reference to the relative value of that asset class (expressed as a percentage).

19    The conclusions I have reached are as follows:

(a)    the claim made by the plaintiffs in respect of items 11 and 12 of the plaintiffs' amended notice of claim is dismissed;

(b)    the claim made by Westpac is upheld and it is entitled to a proportionate share of the balance of the Retained Proceeds reflecting the relative value of the assets of Sargon Services sold pursuant to the Business Sale Agreement and the shares in REP, Tidswell, Mammatus, Sargon CT and Sargon CT NSW, which I have determined to be 65.5%;

(c)    the claim made by Sargon Capital and Taiping is upheld and they are entitled to a proportionate share of the balance of the Retained Proceeds reflecting the relative value of the assets of Sargon Capital sold pursuant to the Business Sale Agreement which I have determined to be 13.1%; and

(d)    the claims made by GrowthOps, and Diversa and OneVue, in the proceeding are dismissed.

20    For completeness, I have determined that the relative value of DTL and CCSL is 21.4% and the relative value of Sargon NZ is nil.

21    For the avoidance of doubt, the amounts payable to Westpac and Sargon Capital from the Retained Proceeds are to be calculated and paid only after the amounts due to the plaintiff have been paid in accordance with the order of the Court made on 20 January 2021 (including the final determination of amounts due in respect of paragraph 1(a) of that order).

B.    NOTIFIED CLAIMS

22    The plaintiffs filed a claim on 15 May 2020 and served an amended notice of claim on 18 December 2020. As stated above, almost the entirety of the plaintiffs’ claim was resolved by the consent order made on 20 January 2021, including the plaintiffs’ claim for their reasonable remuneration, costs and expenses. The unresolved claim, being items 11 and 12 of the amended notice of claim, is a claim for pre-appointment priority employee entitlements owing by Sargon Services under ss 556(1)(e)-(h) of the Corporations Act. The plaintiffs contend that, by reason of s 561 of the Corporations Act, those entitlements are required to be met from that proportion of the Retained Proceeds that reflects the value of Sargon Services’ circulating assets that were sold pursuant to the Business Sale Agreement (and must be paid in priority to Westpac’s security interests over those circulating assets).

23    Westpac filed a claim on 15 May 2020. Westpac claims to be owed some $32,000,000 under loan facilities granted to Re Holdco, RSE Holdco and Sargon CT Holdings and facilities for bank guarantees to Sargon Services. Those facilities were secured by general security agreements over the assets of those entities and Mammatus. The Mammatus general security agreement was released on 4 May 2020, but the rights of Westpac as against the Retained Proceeds were preserved in relation to security over the assets of Mammatus due to paragraph 6 of the orders made on 1 May 2020. Westpac therefore claims that proportion of the Retained Proceeds that reflects the value of:

(a)    the assets of Sargon Services sold pursuant to the Business Sale Agreement; and

(b)    the shares in REP, Tidswell, Mammatus, Sargon CT and Sargon CT NSW,

up to the amounts owing to Westpac under each relevant facility.

24    Sargon Capital and Taiping filed a notice of claim on 15 May 2020. Sargon Capital claims an ownership interest in certain assets which were sold pursuant to the Business Sale Agreement comprising software, website, trade marks and domain names. Taiping has a registered security interest against Sargon Capital on the Personal Property Securities Register comprising a general security deed. Under that deed, Taiping holds a security interest over all of the present and after-acquired property of Sargon Capital including a charge over intellectual property. Sargon Capital and Taiping therefore claim that proportion of the Retained Proceeds that reflects the value of the intellectual property owned by Sargon Capital and sold pursuant to the Business Sale Agreement. As the interests of Sargon Capital and Taiping are aligned, references in these reasons to the interests and submissions of Sargon Capital should be understood as including Taiping.

25    GrowthOps filed a notice of claim on 15 May 2020. In the notice, GrowthOps claimed an interest in two categories of assets sold pursuant to the Business Sale Agreement. The first was an ownership interest in intellectual property created by GrowthOps under the Technology Master Services Agreement (having a commencement date of 1 July 2019) (Technology MSA) and the Master Services Agreement (Creative, Marketing, Coaching & Leadership) (having a commencement date of 2 September 2019) (Marketing MSA) and provided to Sargon Capital, but for which GrowthOps had not been paid (being an amount of $1,854,621.11 as at 13 May 2020 with costs and interest continuing to accrue in accordance with the terms of the Technology MSA and Marketing MSA). Such intellectual property is referred to in those agreements as the “Developed IP”. The second category was an interest, as licensor, of the royalty free licence of “GrowthOps Background IP” granted to Sargon Capital pursuant to the Technology MSA. The claim for the second category of asset was not pressed by GrowthOps at the hearing. GrowthOps therefore claims that proportion of the Retained Proceeds that reflects the value of the Developed IP sold pursuant to the Business Sale Agreement (up to the total amount owing under the Technology MSA and Marketing MSA).

26    Diversa filed a notice of claim on 15 May 2020. In the notice, Diversa claims a vendor's equitable lien over the shares in CCSL and DTL to the extent that it has not been paid the purchase price for its sale of those shares to Sargon SH and Sargon SPV pursuant to a Share Purchase Agreement dated 20 December 2018. The total purchase price under the Share Purchase Agreement (as varied) was $43 million, to be paid by way of an initial purchase price of $12 million and then a deferred purchase price of $31 million. The initial purchase price has been paid. The deferred purchase price, which became immediately payable on 3 February 2020 when administrators were appointed to Sargon SH and Sargon SPV, remains largely unpaid. Diversa has undertaken to limit its claim as a secured creditor to no more than $8 million of the proceeds of the Cloverhill Sale. Diversa therefore claims that proportion of the Retained Proceeds that reflects the value of the shares in CCSL and DTL up to $8 million. As the interests of Diversa and OneVue are aligned, references in these reasons to the interests and submissions of Diversa should be understood as including OneVue.

C.    QUESTIONS TO BE DETERMINED

27    In accordance with orders made on 31 August 2020, the parties filed a joint statement of the questions to be determined by the Court on the notified claims. As these reasons address each of the questions as framed by the parties, it is appropriate to set out that statement in full:

JOINT STATEMENT OF QUESTIONS TO BE DETERMINED BY THE COURT

1.    INTRODUCTION

1.1    On 4 May 2020, certain property of the Sargon Group (but some of which is claimed to have been owned by GrowthOps), was sold to Pacific Infrastructure Services Pty Ltd and Pacific Infrastructure Holdings Pty Ltd (Cloverhill Sale) pursuant to orders made under section 442C of the Corporations Act 2001 (Cth).

1.2    This document is filed in respect of paragraph 2(b) of the orders of the Federal Court of Australia made on 31 August 2020 which provided that the parties confer and seek to agree and file with the Court a joint statement of the questions to be determined on the Claims as defined in those orders.

1.3    In this document:

(a)    Developed IP has the meaning in paragraphs 15 and 19 of the McMenamin Affidavit.

(b)    McMenamin Affidavit means the affidavit of Craig McMenamin filed in this proceeding and dated 12 June 2020.

(c)    Marketing MSA, Quarterly Growth Plans, Statements of Work, Systems and Technology MSA all have the same meaning as in the McMenamin Affidavit.

2.    VALUATION DATE AND BASIS OF VALUATION

2.1    On what basis should:

(a)    the shares; and

(b)    the assets

sold under the Cloverhill Sale be valued; for example, a fair market value basis?

2.2    On what date should:

(a)    the shares; and

(b)    assets

sold under the Cloverhill Sale be valued?

3.    OWNERSHIP OF ASSETS

Sargon Capital and Sargon Services

3.1    As at the date of the Cloverhill Sale (being 4 May 2020), did Sargon Capital Pty Ltd (Sargon Capital) or Sargon Services Pty Ltd (Sargon Services) own:

(a)    the domain name, www.sargon.com;

(b)    the business name, Good Super;

(c)    the trademarks listed in items 1 to 7 of part A of schedule 8 of the Business Sale Agreement [being the agreement dated 4 May 2020 between Sargon Services, Pacific Infrastructure Services Pty Ltd, Stewart McCallum, Adam Nikitins and the entities listed in schedule 2 of that agreement];

(d)    the domain names listed in items 8 to 14 and 17 to 32 of part B of schedule 8 of the Business Sale Agreement; and

(e)    the domain names listed in items 15 and 16 and 33 to 35 of part B of schedule 8 of the Business Sale Agreement?

Other intellectual property

3.2    How should any value attributed to the "Sargon Trustee Cloud Software", as referred to in the expert reports of Jeff Hall, be divided between Sargon Capital, Sargon Services and GrowthOps?

3.3    How should any value attributed to the "Software technology", as referred to in the expert reports of Antony Samuel, be divided between Sargon Capital, Sargon Services and GrowthOps?

3.4    What part, if any, of the Additional IP comprises intellectual property rights in software that GrowthOps developed in relation to the following systems:

(a)    Arcadia;

(b)    Pay;

(c)    Impact;

(d)    Sentinel; and

(e)    Metropolis,

and which it describes as Developed IP?

3.5    As at the date of the Cloverhill Sale (being 4 May 2020), was the Developed IP (or any part of it) owned by Sargon Capital, Sargon Services or GrowthOps?

3.6    Was the Developed IP sold as part of the Cloverhill Sale so as to generate part of the Retained Proceeds?

3.7    To the extent (if any) to which GrowthOps does not own the Developed IP, is it entitled to any compensation with respect to its claim that it has granted a licence in favour of Pacific Infrastructure Services Pty Ltd for the Background IP, as referred to in paragraph 35 of the McMenamin Affidavit?

3.8    If the answer to question 3.7 is yes, is GrowthOps' claim to compensation for the Background IP secured by any asset that was sold as part of the Cloverhill Sale?

Diversa

3.9    Does Diversa Pty Ltd have a vendor's equitable lien over the shares of CCSL Limited and Diversa Trustees Limited to the extent that it has not been paid the purchase price for the sale of those shares to Sargon Superannuation Holdings Pty Ltd and Sargon Superannuation Holdings SPV Pty Ltd?

4.    VALUATION AND ATTRIBUTION

4.1    What is the proportion of the Retained Proceeds that should be attributed to each of:

(a)    the shares in each of:

(i)    the Responsible Entity Partners Limited;

(ii)    Tidswell Financial Services Ltd;

(iii)    Mammatus Pty Ltd;

(iv)    Sargon CT (NSW) Pty Ltd;

(v)    Sargon CT Pty Ltd;

(vi)    Sargon Limited (a company registered in New Zealand);

(vii)    Diversa Trustees Limited; and

(viii)    CCSL Limited; and

(b)    the assets sold under the Business Sale Agreement and, in particular:

(i)    the domain name www.sargon.com;

(ii)    the intellectual property comprising the computer programs Arcadia, Pay, Impact, Sentinel and Metropolis;

(iii)    intellectual property rights in software that GrowthOps claims to have developed in relation to the following systems: (a) Arcadia, (b) Pay, (c) Impact, (d) Sentinel and (e) Metropolis, and which it describes as Developed IP,

(iv)    the following two alternatives:

(A)    "Sargon Trustee Cloud Software", as referred to in the expert reports of Jeff Hall, including what proportion of this asset, if any, comprises Developed IP; or

(B)    the "Website" and "Software technology", as referred to in the expert reports of Antony Samuel, including what proportion of this asset, if any, comprises Developed IP;

(v)    the plant and equipment of Sargon Services;

(vi)    the business name, Good Super;

(vii)    the trademarks listed in items 1 to 7 of part A of schedule 8 of the Business Sale Agreement;

(viii)    the domain names listed in items 8 to 14 and 17 to 32 of part B of schedule 8 of the Business Sale Agreement;

(ix)    the domain names listed in items 15 and 16 and 33 to 35 of part B of schedule 8 of the Business Sale Agreement; and

(x)    any licence in respect of the Background IP with respect to which GrowthOps claims an entitlement to the Retained Proceeds?

4.2    What amount should be allocated to the Plaintiffs from the Retained Proceeds for their reasonable remuneration, costs and expenses, including in accordance with the principles set out in Re Universal Distributing Co Ltd (in liq) (1933) 48 CLR 171 and how should that be allocated to the shares and assets referred to in paragraph 4.1 above?

4.3    In light of the matters in paragraphs 4.1 and 4.2, what amounts should be allocated to each of the Interested Parties from the Retained Proceeds?

5.    COSTS

5.1    What orders should be made in relation to costs?

28    For the reasons expressed earlier in respect of the notified claims, questions 3.7, 3.8, 4.1(b)(x) and 4.2 do not require answers in this proceeding.

29    In relation to the unresolved aspect of the plaintiffs’ claim, being items 11 and 12 of the plaintiffs’ amended notice of claim, the plaintiffs seek the Court to determine, in connection with question 4.1(b), the proportion of the Retained Proceeds that should be attributed to Sargon Services’ receivables sold pursuant to the Business Sale Agreement.

D.    OVERVIEW OF THE EVIDENCE

Joint Statement of Agreed Facts

30    The parties have filed and tendered a Joint Statement of Agreed Facts which sets out the background to the issues to be resolved in this proceeding. The Joint Statement of Agreed Facts is reproduced in full in Section E below.

Plaintiffs’ witness

31    The plaintiffs read the affidavits of Stewart Alexander McCallum dated 30 April 2020, 1 May 2020 and 29 May 2020. Mr McCallum is one of the plaintiffs. He is a partner of Ernst & Young (EY) and is a chartered accountant and a Registered Liquidator of the Supreme Court of Victoria and the Federal Court of Australia. He has in excess of 20 years’ experience in corporate insolvency, restructuring and forensic accounting. Mr McCallum gave evidence about the administration of the Sargon VA Entities and the Cloverhill Sale, including the claims that have been made by the plaintiffs and the respondents to the proceeds of the sale. Mr McCallum was cross-examined. There was no challenge to his credit and I accept his evidence.

Westpac’s witnesses

32    Westpac read an affidavit of Peter Gage Sise dated 12 June 2020. Mr Sise is a solicitor employed by the solicitors for Westpac in this proceeding, Clayton Utz. Mr Sise was not cross-examined.

33    Westpac also read an affidavit of John Gregory McKillop dated 12 June 2020. Mr McKillop is employed by Westpac as a Senior Account Manager—Credit Restructuring. Mr McKillop gave evidence about the loan facilities provided by Westpac to certain of the Sargon VA Entities and the securities given in respect of those loans. Mr McKillop was not cross-examined.

34    Westpac also read an affidavit of Sophia Alice Griffiths-Mark dated 24 July 2020. At the time of swearing her affidavit, Ms Griffiths-Mark was a graduate-at-law employed by the solicitors for Westpac in this proceeding, Clayton Utz. Ms Griffiths-Mark gave evidence about internet searches conducted by her to seek to identify the registrant of certain domain names relevant to the proceeding. Ms Griffiths-Mark was not cross examined.

Sargon Capital / Taiping witness

35    Sargon Capital and Taiping read two affidavits of Shaun Fraser dated 12 June 2020 and 14 August 2020. Mr Fraser is a Registered Liquidator and a partner in McGrathNicol, a firm of chartered accountants who provide restructuring and advisory services. Mr Fraser is one of the receivers and managers appointed to Sargon Capital (together with Mr Jason Preston). Mr Fraser gave evidence concerning Sargon Capital and its business and Taiping’s loan to, and security interest over, Sargon Capital. Mr Fraser was not cross-examined.

GrowthOps’ witness

36    GrowthOps read two affidavits of Craig McMenamin dated 12 June 2020 and 24 July 2020. Mr McMenamin is the Chief Financial Officer and Company Secretary of the parent company of GrowthOps and is also the company secretary of GrowthOps. Mr McMenamin was not cross-examined.

Diversa witness

37    Diversa read an affidavit of Ashley Mark Fenton dated 24 July 2020. Mr Fenton is the Chief Financial Officer of OneVue and a Company Secretary of Diversa. Mr Fenton was not cross-examined.

Expert valuation reports

38    Expert valuation reports were tendered on behalf of each of Westpac, Sargon Capital and Taiping, and Diversa.

39    Westpac tendered a report dated 24 July 2020 and a supplementary report dated 14 August 2020 of Jeffrey Lewis Hall. Mr Hall holds a B.Sc. (Summa Cum Laude) in Accounting from Kansas State University and a Master of Commerce in Finance from the University of New South Wales. He is a Chartered Financial Analyst and a member of the CFA Society, a Certified Public Accountant and a member of the American Institute of Certified Public Accountants and a Chartered Accountant and member of the Australian Institute of Chartered Accountants. Mr Hall was a founder of Sumner Hall Associates Pty Ltd and has been a director since 2002 and is currently the Managing Director. Sumner Hall Associates is a specialist advisory firm providing corporate advisory services in relation to mergers and acquisitions, divestments, capital raisings, corporate restructuring and financial matters generally. One of the principal activities of the firm is the preparation of corporate and business valuations. Between 1989 and 2001, Mr Hall was Executive Director and shareholder of Grant Samuel & Associates Pty Limited, an investment banking firm.

40    Sargon Capital and Taiping tendered a report dated 24 July 2020 and a supplementary report dated 14 August 2020 of Antony Bryn Samuel. Mr Samuel holds a Bachelor of Commerce degree from the University of Western Australia and is a Chartered Accountant (Australia). He is Managing Director of Sapere Research Group Limited, leading Sapere’s forensic accounting and valuation team, and is a former partner of PwC in London and Sydney with over 20 years of experience as an accountant.

41    Diversa tendered a report dated 24 July prepared by Campbell Jaski, a Partner in the Corporate Value Advisory practice at PwC. Mr Jaski has over 25 years of experience in corporate finance, valuation and business management. He studied corporate finance and valuation theory at the Stern School of Business, New York University and Melbourne Business School, Melbourne University. He is an accredited Business Valuation Specialist with Chartered Accountants Australia and New Zealand and is a Fellow of the Financial Services Institute of Australasia. He is also a Fellow of the Chartered Institute of Arbitrators. For the past 12 years, Mr Jaski has specialised in the valuation of businesses, shares, intangible assets, projects and financial instruments. Prior to this, Mr Jaski worked for Rio Tinto Limited.

42    In accordance with orders of the Court, the parties prepared a Joint Statement of Questions for Expert Valuers which was filed on 5 November 2020. The valuation experts conferred before trial and prepared a joint report dated 1 December 2020 (Joint Expert Report). The Joint Expert Report summarises the experts’ areas of agreement and disagreement in relation to the Joint Statement of Questions for Expert Valuers and the basis of those opinions.

43    The expert valuers were cross-examined concurrently. None of the witnesses changed their opinions in the course of cross-examination, but the cross-examination helped to distil and explain the differences in approach that had been taken by each of the experts.

44    In my view, each of the experts is suitably qualified to express opinions on the relative values of the shares and assets sold as part of the Cloverhill Sale. Further, I consider that each of the experts had a reasoned basis for the opinions they expressed. While the conclusions reached by each expert as to relative value generally favoured the party that had called the expert, that circumstance did not cause me to doubt the sincerity with which the opinions were advanced. Many of the issues debated between the experts involved matters of judgment for which no answer could be said to be right or wrong in an absolute sense. Ultimately, though, I have formed the judgment that certain approaches to the issues in dispute are preferable, which I explain below.

Business records

45    Various business records were tendered by the parties. I made rulings on evidentiary objections during the hearing. Only one objection was the subject of substantive argument, being the admissibility of an announcement published on the Sargon website following the Cloverhill Sale (Sale Announcement). The relevant parts of the Sale Announcement were as follows:

Pacific Infrastructure Partners (‘PIP’), a new entity formed for the purpose of investing in technology-enabled financial services, today announces the completion of the acquisition of key operating entities and assets of the Sargon Capital group of companies (‘Sargon’).

New York-based financiers Teddy Wasserman and Australian Matthew Kibble led the transaction through Cloverhill Group LLC and Kibble Holdings LLC respectively. They are joined as equity shareholders in PIP by Vista Credit Partners (‘VCP’), who also provided financing for the transaction. VCP is a strategic credit investor and financing partner offering a variety of capital solutions to the enterprise software, data and technology market. VCP is the credit-lending arm of Vista Equity Partners (‘Vista’), a leading global technology investor.

Cloverhill Group Managing Partner, Teddy Wasserman said, “We believe the proprietary next-generation trustee infrastructure that Sargon has developed to be world-class technology. …”

The cloud-based platform developed by Sargon delivers clients greater transparency over funds and reduces costs and complexity, while at the same time providing more scalable and reliable operations.

David Flannery, President of Vista Credit Partners, said, “This is a tremendous asset class and Australia is recognised as having one of the best models of superannuation and retirement savings in the world. Vista and VCP have a long and proud track-record of backing companies like Pacific Infrastructure Partners, which are at the forefront of digital transformation and have the intellectual property capable of winning on a global stage.

…

Pacific Infrastructure Partners (PIP) is a new entity formed for the purpose of investing in the financial services industry to support the delivery of strong, independent, technology-enabled trustee solutions. In May 2020, PIP completed the acquisition of the key operating entities and assets of financial technology and infrastructure company, Sargon, including Sargon’s trustee, corporate trust and responsible entity operations, and its proprietary technology infrastructure. …

46    Sargon Capital and Taiping sought to tender the Sale Announcement as evidence relevant to the assessment of the value of the intellectual property sold as part of the sale. The relevant facts asserted in the announcement include that the new owners of the Sargon business that was sold held the opinion that the trustee infrastructure (software) developed by Sargon is “world-class technology”.

47    The evidence is hearsay under s 59 of the Evidence Act 1995 (Cth) (Evidence Act) and is inadmissible unless an exception applies. I allowed the evidence as a business record within s 69 of the Evidence Act. As I stated in Rodney Jane Racing Pty Ltd v Monster Energy Company [2019] FCA 923; 370 ALR 140 at [178], whether a webpage can be shown to be a business record within the meaning of s 69 depends upon the content of the webpage and what is able to be established (whether directly or by inference) about the content of the page. In the present case, I am satisfied that the Sale Announcement:

(a)    forms part of the records belonging to that part of the business of the Sargon Group that was sold (the sale included the Sargon website);

(b)    was made for the purposes of that business, to inform (amongst others) present and prospective customers of the sale; and

(c)    was made by a person who might reasonably be supposed to have had personal knowledge of the relevant facts asserted in the announcement because the statements were made by the representatives of the purchasers about their opinions of the assets that were purchased.

48    While the Sale Announcement is admissible evidence, I do not place significant weight on the evidence. The opinions expressed in the announcement are stated at a high level of generality and do not greatly assist in seeking to attribute a value to the software relative to the other assets sold in the Cloverhill Sale. The opinions must also be discounted to some extent in recognition that a purchaser of a business will likely wish to promote the acquisition that has been made.

E.    JOINT STATEMENT OF AGREED FACTS

49    The parties tendered a Joint Statement of Agreed Facts. It is convenient to reproduce that statement in full because it sets out the primary background facts which were not controversial. Annexures A and B to the Joint Statement of Agreed Facts, which contain diagrams of the corporate structure of the Sargon Group and security interests held or claimed by the parties, are reproduced at the end of these reasons.

PROPOSED JOINT STATEMENT OF AGREED FACTS

1.    INTRODUCTION

1.1    This document is filed in respect of paragraph 2(a) of the Orders of the Federal Court of Australia made on 31 August 2020 which provided that the parties confer and seek to agree and file with the Court a statement of agreed facts in relation to the Claims as defined in those orders.

2.    THE SARGON GROUP

2.1    The Sargon Group was a corporate group consisting of approximately 39 companies which conducted a series of financial planning, corporate trustee, responsible entity, superannuation and related financial services businesses (Sargon Group).

2.2    Sargon Capital Pty Ltd (Receivers and Managers Appointed) (In Liquidation) ACN 608 799 873 (Sargon Capital) was at all relevant times, the ultimate holding company of the Sargon Group, but did not itself engage in any trading activities.

2.3    Sargon Capital was at all relevant times the sole shareholder of each of the following ten Intermediate Holding Companies:

(a)    RE Holdco Pty Ltd ACN 612 592 471 (RE Holdco);

(b)    RSE Holdco Pty Ltd ACN 612 586 893 (RSE Holdco);

(c)    Sargon Services Pty Ltd ACN 163 522 058 (Sargon Services);

(d)    Safewealth Realty Pty Ltd ACN 100 933 980 (Safewealth);

(e)    SC International Holdings 1 Pty Ltd ACN 621 160 101 (SCIH1);

(f)    SC Australian Holdings 1 Pty Ltd ACN 624 531 237 (SCAH1);

(g)    Sargon CT Holdings Pty Ltd ACN 628 621 321 (Sargon CT);

(h)    Sargon International Holdings 2 Pty Ltd ACN 630 632 343 (SIH2);

(i)    Sargon Superannuation Holdings Pty Ltd ACN 630 648 225 (SSH), which in turn was the sole shareholder of Sargon Superannuation Holdings SPV Pty Ltd ACN 633 509 494 (Sargon SPV); and

(j)    Decimal Software Pty Ltd ACN 009 235 956 (Decimal).

2.4    Each of the above Intermediate Holding Companies (with the exception of Safewealth) was in turn a parent company of at least one subsidiary entity. These subsidiary entities along with Sargon Services were the operating business entities of the Sargon Group (Operating Subsidiaries).

2.5    The diagram below provides an overview of the Relevant Operating Subsidiaries (as defined at 2.6 below) within the Sargon Group (shaded in blue). A larger and more detailed structure diagram of the Sargon Group is provided at Annexure A.

2.6    The Operating Subsidiaries that are the subject of the Cloverhill Proceedings and the Cloverhill Sale (defined below) are:

(a)    CCSL Ltd ACN 104 967 964 (CCSL) (a subsidiary of SSH );

(b)    Diversa Trustees Ltd ACN 006 421 638 (DTL) (3,142,333 shares in which were owned by SSH and 2,000,000 shares in which were owned by Sargon SPV);

(c)    Mammatus Pty Ltd ACN 101 393 435 (Mammatus) (a subsidiary of Sargon Services);

(d)    Responsible Entity Partners Limited ACN 119 757 596 (a subsidiary of RE Holdco);

(e)    Sargon CT (NSW) Pty Ltd ACN 000 329 706 (Sargon CT (NSW)) (a subsidiary of Sargon CT);

(f)    Sargon CT Pty Ltd ACN 106 424 088 (a subsidiary of Sargon CT);

(g)    Sargon Ltd NZBN 9429047195639 (a subsidiary of SIH2); and

(h)    Tidswell Financial Services Ltd ACN 010 810 607 (a subsidiary of RSE Holdco).

(Collectively, Relevant Operating Subsidiaries).

2.7    Sargon Services provided a number of the Operating Subsidiaries (save for SSH and its Relevant Operating Subsidiaries, CCSL and DTL, up until 1 January 2020) with labour and administrative services under various services agreements. Sargon Services provided labour and administrative services for SSH and its Relevant Operating Subsidiaries, CCSL and DTL, from 1 January 2020 onwards.

3.    PROPERTY OF THE SARGON GROUP

3.1    The assets of each of the Sargon Group's operating businesses were held by the various Operating Subsidiaries or by Sargon Capital itself.

3.2    The property of the Sargon Group that is the subject of the Cloverhill Proceedings is as follows:

(a)    much of the business and general assets of the Sargon Group, including all of the assets of each of the Relevant Sargon Entities (defined at 7.2 below);

(b)    the share capital of the Relevant Operating Subsidiaries; and

(c)    the intellectual property associated with the Sargon Group (noting that GrowthOps claims an interest in a subset of the intellectual property).

3.3    As described in more detail in section 9 below, the above property was sold by a number of the Intermediate Holding Companies to Pacific Infrastructure Services Pty Ltd ACN 640 130 712 (Pacific Services) and Pacific Infrastructure Holdings Pty Ltd ACN 640 129 479 (Pacific Holdings) as part of a complete sale of the business to the Cloverhill Group (Cloverhill Sale).

4.    THE PARTIES TO THE CLOVERHILL PROCEEDINGS

4.1    There are seven active parties in proceeding VID 285/2020 (Cloverhill Proceedings), being:

(a)    the Plaintiffs (Stewart McCallum and Adam Nikitins of Ernst & Young) (Administrators);

(b)    Westpac Banking Corporation ACN 007 457 141 (Westpac) (the First Interested Party);

(c)    Sargon Capital (the Second Interested Party);

(d)    Taiping Trustees Limited (A company registered in Hong Kong) (Trade Register number 0821942) (Taiping) (the Third Interested Party);

(e)    GrowthOps Services Pty Ltd ACN 626 208 777 (GrowthOps) (the Fourth Interested Party);

(f)    Diversa Pty Ltd ACN 079 201 835 (Diversa) (the Fifth Interested Party); and

(g)    OneVue Holdings Limited ACN 108 221 870 (OneVue) (the Sixth Interested Party).

4.2    The interests of the Second and Third Interested Parties are aligned such that there is no need to distinguish between them. The same applies to the Fifth and Six Interested Parties.

5.    SECURITY INTERESTS

5.1    In this section, the facts relevant to the circumstances in which each of the parties came to have interests in the Cloverhill Proceedings are set out, in as close to a chronological order as is possible, except in the case of Westpac's loan facilities and security interests where they are set out according to the Operating Subsidiary, which is more convenient given Westpac had numerous lending arrangements with several entities.

5.2    An overview of the claimed security interests of the parties over the relevant entities to the Cloverhill Proceedings is set out in the following diagram. A larger and more detailed structure diagram of the structure of the Sargon Group is provided at Annexure B.

Taiping's Secured Promissory Note, Guarantee and Indemnity and GSD

5.3    Taiping was incorporated on 15 November 2002 under the laws of Hong Kong. Taiping is a subsidiary of the China Taiping Group, of which China Taiping Insurance Group Limited is the ultimate holding company. China Taiping Insurance Group Limited is a Chinese state-owned financial and insurance group that is headquartered in Hong Kong and has been listed on the Hong Kong Stock Exchange since 2000.

5.4    Phillip Kingston was both a managing director of Sargon Capital and the sole director of Trimantium Investment Management Pty Ltd (Receivers and Managers Appointed) (In Liquidation) ACN 624 073 196 (TTIM).

5.5    On 9 February 2018, Taiping and TTIM entered into a Secured Promissory Note, under which Taiping agreed to advance to TTIM a total of HKD $500,000,000 (approximately AUD $81,000,000) (Secured Promissory Note).

5.6    The Secured Promissory Note was also executed by Sargon Capital as obligor.

5.7    To further secure the performance of the obligations of TTIM, Sargon Capital provided the following security documents in favour of Taiping:

(a)    a Guarantee and Indemnity dated 27 April 2018 (Sargon Capital Guarantee); and

(b)    a General Security Deed dated 27 April 2018 (Sargon Capital GSD).

5.8    The Sargon Capital GSD was registered on the Personal Property Securities Register (PPSR) (Registration Number 201804090021528) on 9 April 2018.

5.9    Under the terms of the Sargon Capital GSD, Taiping was granted a security interest over all of the present and after-acquired property of Sargon Capital. In particular, Taiping was granted a charge over any intellectual property, including:

(a)    a patent, trademark or service mark, copyright, registered design, trade secret or confidential information; or

(b)    a licence or other right to use or to grant the use of any of the above, or to be the registered proprietor or user of any of the above.

Westpac

RE Holdco

5.10    On or about 15 October 2018, Westpac provided a loan facility to RE Holdco with a limit of $5,000,000. The loan facility is secured by:

(a)    an unlimited guarantee and indemnity granted by Sargon Services in favour of Westpac dated 30 October 2018;

(b)    an unlimited interlocking guarantee and indemnity granted by RSE Holdco, RE Holdco and Sargon CT in favour of Westpac dated 30 October 2018 (Interlocking Guarantee and Indemnity);

(c)    an unlimited guarantee and indemnity granted by Mammatus in favour of Westpac dated 30 October 2018 which was released on 4 May 2020;

(d)    a general security agreement granted by Sargon Services in favour of Westpac dated 30 October 2018 with PPSR registration number 201811010064791 (Sargon Services GSA);

(e)    a general security agreement granted by RSE Holdco in favour of Westpac dated 4 July 2016 with PPSR registration number 201607080019959 (RSE Holdco GSA);

(f)    a general security agreement granted by RE Holdco in favour of Westpac dated 4 July 2016 with PPSR registration number 201607080019786 (RE Holdco GSA);

(g)    a general security agreement granted by Sargon CT in favour of Westpac dated 30 October 2018 with PPSR registration number 201811010067224 (Sargon CT GSA); and

(h)    a general security agreement granted by Mammatus in favour of Westpac dated 30 October 2018 formerly with PPSR registration number 201811010064988 (Mammatus GSA). The Mammatus GSA was released on 4 May 2020.

RSE Holdco

5.11    On or about 15 October 2018, Westpac provided a loan facility to RSE Holdco with a limit of $600,000. The loan facility is secured by:

(a)    an unlimited guarantee and indemnity granted by Sargon Services in favour of Westpac dated 30 October 2018;

(b)    the Interlocking Guarantee and Indemnity;

(c)    an unlimited guarantee and indemnity granted by Mammatus in favour of Westpac dated 30 October 2018 which was released on 4 May 2020;

(d)    the Sargon Services GSA;

(e)    the RSE Holdco GSA;

(f)    the RE Holdco GSA;

(g)    the Sargon CT GSA; and

(h)    the Mammatus GSA. The Mammatus GSA was released on 4 May 2020.

Sargon CT

5.12    On or about 15 October 2018, Westpac provided two loan facilities to Sargon CT with limits of $12,000,000 and $10,000,000 respectively.

5.13    On or about 24 December 2019, Westpac provided another loan facility to Sargon CT with a limit of $6,000,000.

5.14    The loan facilities provided to Sargon CT are secured by:

(a)    an unlimited guarantee and indemnity granted by Sargon Services in favour of Westpac dated 30 October 2018;

(b)    the Interlocking Guarantee and Indemnity;

(c)    an unlimited guarantee and indemnity granted by Mammatus in favour of Westpac dated 30 October 2018 which was released on 4 May 2020;

(d)    the Sargon Services GSA;

(e)    the RSE Holdco GSA;

(f)    the RE Holdco GSA;

(g)    the Sargon CT GSA; and

(h)    the Mammatus GSA. The Mammatus GSA was released on 4 May 2020.

Sargon Services

5.15    Westpac provided the following facilities for bank guarantees in respect of Sargon Services:

(a)    on or about 7 June 2018, a bank guarantee in favour of Circuit Recruitment Group (Vic) Pty Ltd ACN 141 687 747 for the amount of $60,942.04;

(b)    on or about 5 July 2019, a bank guarantee in favour of BGH (287 Collins) Pty Ltd ACN 623 369 899 for the amount of $111,839.00; and

(c)    on or about 20 August 2019, a bank guarantee in favour of IPAR Rehabilitation Pty Ltd ACN 104 234 317 for the amount of $59,417.88.

5.16    The bank guarantees remain outstanding and therefore the full amounts (as specified above) were contingently owing.

5.17    These facilities are each secured by the Sargon Services GSA.

Diversa Share Purchase Agreement

5.18    Diversa was incorporated in New South Wales on 3 July 1997 and provides superannuation trustee services. It is a wholly owned subsidiary of OneVue, an ASX listed company (ASX:OVH) that is a wholesale service provider to the wealth management industry.

5.19    Pursuant to a Share Purchase Agreement dated 20 December 2018 and its subsequent variations (Diversa SPA), Diversa sold:

(a)    all of the shares it held in CCSL to SSH;

(b)    3,142,333 of the shares it held in DTL to SSH; and

(c)    2,000,000 of the shares it held in DTL to Sargon SPV.

5.20    Pursuant to the Diversa SPA, the total consideration payable was $43 million to be paid by way of an Initial Purchase Price of $12 million and then a Deferred Purchase Price of $31 million, with the Deferred Purchase Price payable by SSH and Sargon SPV in proportion to the number of CCSL and DTL shares each received under the Diversa SPA.

5.21    Sargon Capital guaranteed to Diversa performance of the obligations of SSH and SPV under the Diversa SPA.

5.22    The Initial Purchase Price component of the consideration for the DTL and CCSL shares has been paid. However, taking into account realisations to date, $28,365,386.31 of the Deferred Purchase Price component of the consideration (and accrued interest owing under the Diversa SPA) remains outstanding.

GrowthOps Technology MSA, Marketing MSA and invoices issued 30 July 2019 – 31 January 2020

5.23    GrowthOps was incorporated in Victoria on 17 May 2018. GrowthOps is a wholly owned subsidiary of the ASX listed company Trimantium GrowthOps Limited ACN 621 067 678 (ASX:TGO) (TGO). Both GrowthOps and TGO provide management consulting, technology, advertising, creative, coaching and leadership services.

5.24    On or around 30 August 2019, GrowthOps and Sargon Capital entered into a Technology Master Services Agreement, with a commencement date of 1 July 2019 (Technology MSA). Significant clauses include 7.1(a), (c) and (d). Clause 7.1(a) provided that "all Intellectual Property Rights in the Services and Deliverables (Developed IP), except any GrowthOps Background IP or its service methodology and knowledge, vests in Sargon immediately upon payment to GrowthOps for same, and GrowthOps hereby assigns, and must procure that its personnel assign, all Intellectual Property Rights in the Developed IP To Sargon. GrowthOps agrees to do all things which may be necessary for these ownership rights to pass to Sargon. At Sargon's request, GrowthOps must provide, and ensure that its personnel or sub-contractors provide consents to or waivers of any moral rights in specific Developed IP. This clause does not in any way derogate from the ability for GrowthOps to utilise the same service methodology for other clients"

5.25    On or around 2 September 2019, GrowthOps and Sargon Capital entered into a Master Services Agreement (Creative, Marketing, Coaching & Leadership), with a commencement date of 2 September 2019 (Marketing MSA). Significant clauses include 7.1(a), (c) and (d). Clause 7.1(a) provided that "all Intellectual Property Rights in the Services and Deliverables (Developed IP), except any GrowthOps Background IP or its service methodology and knowledge, vests in Sargon immediately upon payment to GrowthOps for same, and GrowthOps hereby assigns, and must procure that its personnel assign, all Intellectual Property Rights in the Developed IP To Sargon. GrowthOps agrees to do all things which may be necessary for these ownership rights to pass to Sargon. At Sargon’s request, GrowthOps must provide, and ensure that its personnel or sub-contractors provide consents to or waivers of any moral rights in specific Developed IP. This clause does not in any way derogate from the ability for GrowthOps to utilise the same service methodology for other clients."

5.26    Between 30 July 2019 and 31 January 2020, GrowthOps issued 24 invoices to Sargon Capital totalling $1,649,402.85 (excluding GST). The invoices were described to relate to various technology, creative, marketing, coaching and leadership services to Sargon Capital under the Technology MSA and the Marketing MSA spanning the period 1 July 2019 to 31 January 2020.

5.27    To date, Sargon Capital has only paid two of those invoices, which amount to the sum of $314,128.50 (excluding GST). The balance of the invoices ($1,335,274.35) remains unpaid.

Letters of demand and appointment of the Administrators

5.28    On 2 December 2019, Taiping's solicitors Ashurst issued a letter to TTIM and Sargon Capital stating that TTIM had committed an Event of Default (as defined in the Secured Promissory Note).

5.29    On 19 December 2019, Ashurst sent a further letter on behalf of Taiping to Mr Kingston in his capacity as the sole director of TTIM and as a director of Sargon Capital. The letter notified Mr Kingston that TTIM had failed to pay the interest that was due and payable to Taiping.

5.30    On 20 January 2020, Taiping's solicitors Ashurst issued letters of demand to TTIM and Sargon Capital stating that as at 20 January 2020, the amount of HKD $512,964,934.61 was immediately due and payable, pursuant to the terms of the Sargon Capital Guarantee and Sargon Capital GSD. Both TTIM and Sargon Capital failed to comply with the demands made by Taiping.

5.31    On 3 February 2020, the Administrators were appointed as voluntary administrators to eight of the Intermediate Holding Companies.

5.32    Between 3 February 2020 and 14 May 2020, the Administrators conducted the voluntary administration of the Relevant Sargon Entities (defined at 7.2 below), which culminated in the complete sale of the business to the Cloverhill Group (Cloverhill Sale).

5.33    Further detail about the Administrators' appointment and the Cloverhill Sale is set out in paragraphs 7.2 and 9.1 - 9.21 respectively.

5.34    On 23 April 2020, Clayton Utz (acting on behalf of Westpac) issued notices of demand to (i) Sargon CT for $20,492,044.83, (ii) RSE Holdco for $605,366.68 and (iii) Sargon Services for $20,492,044.83. On 28 May 2020, Clayton Utz issued further notices of demand to (iv) Sargon CT for $6,146,653.62, (v) RE Holdco for $5,074,393.95, (vi) Sargon Services for $60,942.04 and (vii) $111,839. Some of the amounts claimed overlap.

6.    NOTICES OF CLAIM

6.1    On 15 May 2020, the active parties in this matter filed notices of claim. Each of the amounts claimed below are “as at” that date.

6.2    In its notice of claim, Taiping claims that the total amount owing to it is no less than $4,000,000. There is no dispute that this amount is owing.

6.3    In its notice of claim, GrowthOps claims compensation for the sale of intellectual property in which it claims an interest, in an amount equal at least to the unpaid invoices referred to at paragraphs 5.26 - 5.27, together with compensation for the perpetual, irrevocable and royalty free licence in respect of the GrowthOps Background IP (as defined in each of the Technology MSA and the Marketing MSA). GrowthOps claims $1,854,621.11 as at 13 May 2020, including GST, and interest and costs which continue to accrue. There is no dispute that this amount is owing.

6.4    In its notice of claim, Westpac claims that the amount owing to it in respect of the facilities referred to at paragraphs 5.10 - 5.17 is $32,019,961.81 (plus recovery costs and interest accruing after 30 April 2020). There is no dispute that this amount is owing.

6.5    In its notice of claim, Diversa claims that the total amount owing to it in respect of the Diversa SPA is $28,365,386.31. There is no dispute that this amount is owing.

6.6    In their notice of claim, the Administrators claim that the total amount owing to them is $4,255,562.67 (plus further amounts that are subject to quantification and Court approval), pursuant to remuneration, costs, expenses (both current and prospective) and pre-appointment priority employee entitlements owing by Sargon Services. The Administrators’ notice of claim was revised in the third affidavit of Stewart McCallum dated 29 May 2020 and the Administrators’, now Liquidators’ remuneration, costs and expenses in connection with the liquidations of the Relevant Operating Subsidiaries, including in connection with the Cloverhill Proceedings, continues to accrue.

7.    EXTERNAL ADMINISTRATION OF THE SARGON GROUP

7.1    On 29 January 2020, Shaun Fraser and Jason Preston were appointed by Taiping as joint and several receivers and managers of Sargon Capital (Sargon Capital Receivers), and a further two other related companies (Trimantium Capital Funds Management Pty Ltd (Receivers and Managers Appointed) (In Liquidation) ACN 602 329 902 (TCFM) and TTIM.

7.2    On 3 February 2020, Phillip Kingston in his capacity as the sole director of nine of the Intermediate Holding Companies passed resolutions pursuant to section 436A of the Corporations Act 2001 (Cth) (Corporations Act) appointing the Administrators as the voluntary administrators of the following seven Intermediate Holding Companies (plus an eighth Intermediate Holding Company, SCAH1, the assets of which were not sold as part of the Cloverhill Sale):

(a)    Re Holdco;

(b)    RSE Holdco;

(c)    Sargon Services;

(d)    SCIH1;

(e)    Sargon CT;

(f)    SIH2; and

(g)    SSH.

(Collectively, Relevant Sargon Entities).

7.3    Safewealth was not placed into administration.

7.4    As a result of their appointment, the Administrators took control of all of the shares owned by the Sargon Group in the Operating Subsidiaries and all of the employees and documents of the Sargon Group.

7.5    On 3 and 4 February 2020, Matthew Byrnes and David Hodgson of Grant Thornton were appointed as joint and several voluntary administrators of:

(a)    Decimal;

(b)    Decimal Technology and Systems Pty Ltd ACN 118 370 291;

(c)    Decimal Pty Ltd ACN 135 979 743; and

(d)    Simpla Pty Ltd ACN 159 982 671.

(Collectively, Decimal Entities).

7.6    On 4 February 2020, Daniel Walley and Christopher Hill of PricewaterhouseCoopers were appointed as joint and several receivers and managers of SCAH1 by Diversa. SCAH1 and its assets do not form part of the Cloverhill Proceedings.

7.7    On 8 March 2020, Joseph Hayes and Andrew McCabe of Wexted Advisors were appointed as joint and several administrators of Sargon Capital, TTIM and TCFM pursuant to section 436C of the Corporations Act.

7.8    On 10 March 2020, Mr Byrnes and Mr Hodgson were appointed as the liquidators of the Decimal Entities.

7.9    On 8 April 2020, at the second meeting of the creditors of Sargon Capital, it was resolved to wind up Sargon Capital, and Mr Hayes and Mr McCabe were appointed as liquidators pursuant to section 446A of the Corporations Act.

7.10    On 14 May 2020, at the second meeting of creditors of the Sargon Entities, it was resolved to wind up the Relevant Sargon Entities and Mr McCallum and Mr Nikitins were appointed as liquidators (defined in this document as the Administrators: see paragraph 4.1(a) above) pursuant to section 446A of the Corporations Act.

8.    SARGON SERVICES

8.1    Sargon Services employed many of the employees who worked for the Sargon Group, including employees who provided services to the Intermediate Holding Companies and the Operating Subsidiaries. Sargon Services also rented offices that were used by other entities in the Sargon Group.

8.2    The services provided by Sargon Services to Responsible Entity Partners Limited, Tidswell Financial Services Ltd, Sargon CT and Sargon CT (NSW) (for the period of five years starting on 8 May 2019) were in the following categories:

(a)    governance, risk and compliance;

(b)    human resources;

(c)    finance;

(d)    information technology;

(e)    legal;

(f)    product; and

(g)    corporate trustee.

8.3    The services provided by Sargon Services to DTL and CCSL (for the period of one year starting on 19 January 2020, subject to a three-month extension) were in the following categories:

(a)    governance, risk and compliance;

(b)    human resources;

(c)    finance;

(d)    information technology;

(e)    legal; and

(f)    product.

8.4    From 28 June 2019 to 31 December 2019, DTL and CCSL received services of the following kind from OneVue Services Pty Ltd (OneVue Services) pursuant to a Transitional Services Agreement dated 28 June 2019 instead of Sargon Services. DTL and CCSL paid a monthly fee to OneVue Services for those services. The services provided under the Transitional Services Agreement included:

(a)    accounting and financial management (for which DTL and CCSL paid $20,000 per month);

(b)    human resources;

(c)    information technology and cyber security (for which DTL and CCSL paid $20,000 per month);

(d)    legal and litigation support; and

(e)    product development and marketing.

8.5    DTL and CCSL paid $20,000 per month under the Transitional Services Agreement for the services provided by OneVue Services other than accounting and financial management services and information technology and cyber security services (for which the separate monthly fees identified above were paid).

8.6    The total monthly fee paid by DTL and CCSL from July to September was $60,000 (ex GST) per month. In October, November and December 2019, OneVue Services did not provide information technology and cyber security services to DTL and CCSL, so DTL and CCSL paid $40,000 (ex GST) for each of those months.

8.7    After and before the Administrators were appointed:

(a)    on 18 February 2020, Sargon Services entered into an agreement with DTL and CCSL, pursuant to which Sargon Services agreed to provide services to DTL and CCSL in exchange for a fee of $92,000 per month for one year from 19 January 2020 subject to a three-month extension; and

(b)    on 8 May 2019, Sargon Services, Tidswell, Sargon CT (NSW), Sargon CT and REP entered into an agreement pursuant to which Sargon Services agreed to provide each other party to that agreement with services in exchange for a fee fixed at the cost incurred by Sargon Services in providing those services plus a margin of 10% for a period of 5 years, subject to early termination.

8.8    For the period July 2018 to December 2019, Sargon Services incurred the following expenses (as recorded on its profit and loss statement):

(a)    $14,267,649.36 in salary package costs;

(b)    $2,187,131.05 in staff expenses;

(c)    $793,794.11 in professional services expenses; and

(d)    $962,937.72 in occupancy costs;

totalling $18,211,512.24. The total of all of Sargon Services’ expenses for that period was $20,215,913.87.

9.    CLOVERHILL SALE

9.1    Following their appointment on 3 February 2020, the Administrators commenced a sale process in which they advertised all of the shares owned by the Intermediate Holding Companies in the Operating Subsidiaries (other than SCAH1's shares).

9.2    On 10 February 2020, the Administrators provided the Sargon Capital Receivers with a copy of Sargon Capital's balance sheet as at the end of December 2019, which stated that Sargon Capital held, amongst other things, the following assets:

(a)    intercompany loans (with a book value of AUD$115,991,605.11);

(b)    "Intangible tech - Sargon" (with a book value of AUD$5,797,293.90); and

(c)    domain name (with a book value of AUD$237,696.49).

9.3    The balance sheet for Sargon Services as at the end of December 2019 recorded $1,037,554.95 for "Intangible tech - Sargon" which comprised $549,583 for Sargon Technology, $1,053,694.39 for "Website" and -$565,722.44 for "Amortisation of Website".

9.4    Between 17 February 2020 and 10 March 2020, substantial correspondence was exchanged and various conversations occurred between the Sargon Capital Receivers and the Administrators concerning the sale process.

9.5    Between 4 February 2020 and 25 March 2020, the Sargon Capital Receivers made several requests of the Administrators to provide access to Sargon Capital’s books and records, and information relevant to the proposed Cloverhill Sale. The majority of the information requested was not provided to the Sargon Capital Receivers, in part, due to a confidentiality agreement between the Administrators and the Cloverhill Group.

9.6    On or around 18 February 2020, the Cloverhill Group made an offer to the Administrators to purchase all of the assets of some of the Relevant Sargon Entities (among other entities), including the share capital in the Relevant Operating Subsidiaries (among other entities).

9.7    On or about 4 March 2020, a written offer dated 4 March 2020 was made by the Cloverhill Group to purchase all of the assets of each of the Relevant Sargon Entities (among other entities), including the share capital in the Relevant Operating Subsidiaries (among other entities), subject to the fulfilment of various conditions precedent.

9.8    On 10 March 2020, the Sargon Capital Receivers sought confirmation from the Administrators that the proposed sale did not include any assets or property of Sargon Capital, in particular, any intellectual property.

9.9    On 28 March 2020, GrowthOps and the Administrators reached an in-principle agreement that GrowthOps would transfer any rights that it had in the Developed IP (as that term is defined in the Technology MSA and Marketing MSA) to the Cloverhill Group for an agreed payment contingent on the completion of the Cloverhill Sale (Administrators' Proposed Agreement).

9.10    On 29 March 2020, the Administrators informed the Sargon Capital Receivers by letter that at that point in time, Cloverhill Group did intend for the "Sargon Cloud (Software)" to be included in the Cloverhill Sale.

9.11    Between 1 April 2020 and 21 April 2020, the Sargon Capital Receivers and the Administrators engaged in negotiations in relation to the sale of the assets to the Cloverhill Group including the relevant intellectual property.

9.12    On 22 April 2020, Diversa/OneVue and the Administrators reached an in-principle agreement, conditioned on the agreement of Sargon Capital being procured, that Diversa/OneVue would settle its claims in respect of SSH and Sargon SPV for the sum of $2,500,000, to be paid from the purchase price upon completion of the Cloverhill Sale (Diversa Agreement).

9.13    On 22 April 2020, the Administrators sent a letter to the Sargon Capital Receivers that outlined each of the Administrators' Proposed Agreement and Diversa Agreement, and set out what was described to be the final terms upon which Sargon Capital could participate in the sale to the Cloverhill Group. Under the terms of that offer, Sargon Capital would receive approximately $5.1 million for the following assets (of the approximately $30 million being paid by the Cloverhill Group in connection with the Cloverhill Sale):

(a)    $4 million for the IP assets;

(b)    $400,000 for the Intercompany Loans; and

(c)    $722,000 for the estimated dividends payable from the Intermediate Holding Companies' estates

(the Sargon Capital Offer).

9.14    As part of the Sargon Capital Offer, the balance of $30 million (less an amount of $400,000 payable to Decimal) was to be distributed to the other creditors, namely the remaining Interested Parties and the Administrators (for their remuneration and expenses).

9.15    An explanation for the proposed commercial settlement of $4 million for the intellectual property given by the Administrators and contained within the Sargon Capital Offer is given within the 22 April 2020 letter. In particular, annexure A to that letter provided for six estimated outcome scenarios that estimated the total amount of return to Sargon Capital, which ranged from approximately $4.4 million to $5.9 million with "IP and other assets" having the proposed commercial settlement amount of $4 million in each scenario.

9.16    On and from 22 April 2020, there was further communication between the Sargon Capital Receivers and the Administrators.

9.17    On 24 April 2020, negotiations between the Sargon Capital Receivers and the Cloverhill Group resulted in a proposed agreement by which Sargon Capital would assign any rights that it had in the intellectual property rights used in Sargon Services' business, free of Taiping's security interest, to Cloverhill for a sum of $4 million.

9.18    On 28 April 2020, the Sargon Capital Receivers advised the Administrators that it may no longer be possible to secure the release of Taiping's security interest, and that the Sargon Capital Receivers were no longer prepared to agree to an assignment of the interests in the intellectual property that may be held by Sargon Capital.

9.19    On 29 April 2020, the solicitors for the Administrators sent a letter to Ashurst. In this letter, the Administrators encouraged Taiping to accept "the very generous [Sargon Capital Offer] of $4 million to transfer its rights (whatever they may be) in the Sale IP to Cloverhill", and provided views as to the value of the intellectual property.

9.20    Taiping did not accept the Sargon Capital Offer. Neither the Administrators' Proposed Agreement or the Diversa Agreement were ultimately executed.

9.21    On 30 April 2020, the further communications between the Sargon Capital Receivers and the Administrators with respect to the Cloverhill Sale concluded, in conjunction with the commencement of proceedings in the Federal Court (as described in the following section).

10.    CLOVERHILL PROCEEDINGS

10.1    On 30 April 2020, the Administrators filed an application in the Federal Court of Australia pursuant to sections 442C and 447A of the Corporations Act, seeking leave of the Court to complete the Cloverhill Sale.

10.2    On 1 May 2020, Justice O'Bryan made orders approving the completion of the Cloverhill Sale. However, in order to protect the secured parties, the Court ordered that the proceeds of the sale be retained in a separate account (Retained Proceeds), and provided a mechanism for the various claims over the assets of the Sargon Group to be determined by the Court.

10.3    On or about 4 May 2020, the Cloverhill Sale was effected by the execution of:

(a)    the Business Sale Agreement in respect of Sargon dated 4 May 2020 (Business Sale Agreement);

(b)    the following Share Sale Agreements (Share Sale Agreements):

(i)    Share Sale Agreement in respect of Responsible Entity Partners Ltd dated 4 May 2020;

(ii)    Share Sale Agreement in respect of Tidswell Financial Services Ltd dated 4 May 2020;

(iii)    Share Sale Agreement in respect of Mammatus Pty Ltd dated 4 May 2020;

(iv)    Share Sale Agreement in respect of Sargon CT (NSW) Pty Ltd dated 4 May 2020;

(v)    Share Sale Agreement in respect of Sargon CT Pty Ltd dated 4 May 2020;

(vi)    Share Sale Agreement in respect of Sargon Limited (NZ) dated 4 May 2020;

(vii)    Share Sale Agreement in respect of CCSL Limited dated 4 May 2020;

(viii)    Share Sale Agreement in respect of Diversa Trustees Limited to Pacific Infrastructure Holdings Pty Ltd dated 4 May 2020; and

(ix)    Share Sale Agreement in respect of Diversa Trustees Limited to Diversa Holdco Pty Ltd dated 4 May 2020.

10.4    The overall total consideration for the Cloverhill Sale was $29,600,000 (being the $30,000,000 gross proceeds less $400,000 payable to Decimal). That amount comprised:

(a)    $5,463,836 consideration under the Business Sale Agreement; and

(b)    $24,136,164 consideration under the Share Sale Agreements.

10.5    In the Business Sale Agreement, the intellectual property of the Sargon Group is defined and addressed by way of the following:

(a)    Pursuant to Schedule 1:

(i)    "Assets" is defined to include Additional IP and the Business Intellectual Property;

(ii)    "Additional IP" refers to the Sale IP as defined in Order 1 of the orders made on 1 May 2020 and includes the Intellectual Property Rights (including those set out in Schedule 8 to the Business Sale Agreement) but Excludes Business Intellectual Property;

(iii)    "Business Intellectual Property" means all Intellectual Property Rights owned by the Seller and used in the Business, including as set out in Schedule 5, but excludes any rights in or relating to the Sargon name or trademark (other than the Domain Name);

(iv)    "Intellectual Property Rights" means all industrial and intellectual property rights and interests of whatever nature throughout the world conferred under statute, common law or equity, whether existing now or at any time in the future, and includes rights in respect of or in connection with copyright, inventions (including patents), formulae, databases, business processes and methods, circuit layouts, plant varieties, trademarks, service marks, business names, trade names, domain names, designs, confidential information, trade secrets and know-how and similar industrial and intellectual property rights, whether or not registered or registrable, and includes the right to apply for or renew the registration of such rights;

(b)    Pursuant to Schedule 5, the Business Intellectual Property includes the Domain Name (www.sargon.com) registered by Sargon Services;

(c)    Pursuant to Schedule 8:

(i)    Part A sets out seven trademarks, including the trademark "SARGON" with IP Australia registration number 1927649; and

(ii)    Part B sets out 28 domain names, all registered to Sargon Capital.

(d)    There was no specific attribution of the value of the "Additional IP" or "Business Intellectual Property" in the Business Sale Agreement.

10.6    Following the completion of the Cloverhill Sale, an announcement was released on the Sargon website, which stated (amongst other things):

Cloverhill Group Managing Partners, Teddy Wasserman said, "We believe the proprietary next-generation trustee infrastructure that Sargon has developed to be world-class technology". … The cloud-based platform developed by Sargon delivers clients greater transparency over funds and reduces costs and complexity, while at the same time providing more scalable and reliable operations.

The parties agree that this announcement was released but do not agree that any of its contents is necessarily correct.

10.7    On 15 May 2020, pursuant to the orders of Justice O'Bryan dated 1 May 2020, the Interested Parties and the Administrators each filed Notices of Claim with respect to the Retained Proceeds, as addressed in section 6 above.

10.8    On 19 May 2020, Justice O'Bryan delivered written reasons for the orders made on 1 May 2020.

10.9    Various deductions have been made from the Retained Proceeds from time to time, being:

(a)    $351,884 paid to the Australian Taxation Office pursuant to the Orders of Justice O'Bryan dated 4 August 2020;

(b)    $19,470 paid to the mediator, Manny Garantziotis QC, in respect of fees charged for conducting the mediation of the Cloverhill Proceedings on 19 August 2020; and

(c)    $120,653.25 paid to the Victorian and New South Wales State Revenue Offices pursuant to the Orders of Justice O'Bryan dated 15 September 2020.

10.10    As at 21 October 2020, the balance of the Retained Proceeds was $29,093,527.40.

10.11    On 27 August 2020, the Administrators made an application under paragraph 60-10(1)(c) of the Insolvency Practice Schedule (Corporations) (Schedule 2 to the Corporations Act) to have the certain remuneration, referred to in paragraph 6.6 above be determined by the Court.

50    During the hearing, the parties confirmed that, in paragraph 2.3(h), the reference to “Sargon International Holdings 2 Pty Ltd” should be a reference to “SC International Holdings 2 Pty Ltd” (and that change should also be made to the corporate diagrams in the Annexures to these reasons) and that, in paragraph 7.2(d), the reference to “SCIH1” should be a reference to “Sargon SPV”.

F.    QUESTION 2: VALUATION DATE AND BASIS OF VALUATION

51    The first questions for determination (being question 2 in the Joint Statement of Questions) are on what basis, and on what date, should the shares and assets sold under the Cloverhill Sale be valued.

52    The parties were agreed that, for the purposes of this proceeding and the resolution of the competing claims to the Retained Proceeds, the shares and assets sold under the Cloverhill Sale should be valued as at the date of sale, being 4 May 2020.

53    In relation to the basis of value, each of the expert valuers expressed the opinion that, for the purposes of this proceeding and the resolution of the competing claims to the Retained Proceeds, the shares and assets sold under the Cloverhill Sale should be valued at market value or fair market value in order to determine their relative values. However, the methodologies used by each of the experts to determine those values differed considerably. It is convenient to consider the differing methodologies, and state my conclusions in relation to those methodologies, when addressing question 4.

G.    QUESTION 3: OWNERSHIP OF ASSETS

G.1    The claims to ownership of intellectual property assets made by or on behalf of Sargon Capital and Sargon Services

Overview

54    Questions 3.1 to 3.6 concern the intellectual property assets that were sold pursuant to the Business Sale Agreement. Westpac claims that part of those assets were owned by Sargon Services (over which Westpac holds security interests). Sargon Capital and Taiping claim that part of those assets were owned by Sargon Capital. GrowthOps claims that part of those assets were owned by it by reason that it developed software and other materials which are the subject of copyright and retained ownership of the copyright pending payment for its development.

55    The intellectual property assets sold pursuant to the Business Sale Agreement are defined in that agreement. Those definitions are referred to below. By way of overview, the assets can be divided into three broad categories:

Sargon software systems (known as “Arcadia”, “Sentinel”, “Metropolis”, “API Impact”, and “Sargon Pay”);

the Sargon website (which was treated by the parties as a separate species of software); and

numerous trading and domain names.

56    Those assets were the subject of the order of the Court made on 1 May 2020 empowering the plaintiffs (as administrators of Sargon Services) to dispose of the assets (as part of the Cloverhill Sale) notwithstanding that the interested parties may have held ownership or security interests in the assets. Those assets were defined as the “Sale IP” in the Court’s order.

57    Question 3.1 concerns the trading and domain names and asks whether Sargon Services or Sargon Capital was the owner of those assets as at the date of the Cloverhill Sale. Questions 3.2 and 3.3 concern the Sargon software systems and the Sargon website and asks how the value of those software assets should be divided between Sargon Services, Sargon Capital and GrowthOps.

58    Questions 3.4 to 3.6 focus specifically on GrowthOps’ claims to ownership of the Developed IP (being intellectual property developed pursuant to the Technology MSA and the Marketing MSA). In effect, the questions ask whether the Developed IP was sold as part of the Cloverhill Sale (including as part of the Sargon software systems) so as to generate part of the Retained Proceeds and whether GrowthOps was the owner of the Developed IP at the time of sale such that it is entitled to a proportion of the Retained Proceeds.

59    It is convenient to consider the competing claims by Sargon Services and Sargon Capital to ownership of the intellectual property assets sold pursuant to the Business Sale Agreement before considering the claims of GrowthOps. The remainder of this section G.1 addresses that question.

Findings of fact

60    The evidence concerning the ownership of the intellectual property assets (as between Sargon Services and Sargon Capital) was sparse. It primarily consisted of the Business Sale Agreement (to which Sargon Services, but not Sargon Capital, was a party) and the financial accounts of Sargon Services and Sargon Capital. The financial accounts are admissible in evidence and are prima facie evidence of the matters stated or recorded in the accounts: Corporations Act s 1305.

61    Under the Business Sale Agreement, Sargon Services (as Seller) sold the Assets (as defined) to the purchaser. It did so with the authority given to the plaintiffs (as administrators) by the Court on 1 May 2020. Relevantly, the Assets are defined to include the Additional IP (as defined) and the Business Intellectual Property (as defined).

62    The Additional IP is defined as the Sale IP (as defined in the Court’s order of 1 May 2020), including the rights set out in Schedule 8 to the agreement but excluding the Business Intellectual Property. Schedule 8 contains a list of 7 trade marks (including the registered mark SARGON and applications for registration in respect of arcadia, Impact, Sentinel and Metropolis) and 28 domain names (each of which is stated to be registered in the name of Sargon Capital).

63    The Business Intellectual Property is defined as follows:

Business Intellectual Property means all Intellectual Property Rights owned by the Seller and used in the Business, including as set out in Schedule 5 (Business Intellectual Property) but excluding any rights in or relating to the Sargon name or trade mark (other than the Domain Names).

64    The term Intellectual Property Rights is defined in broad terms as follows:

Intellectual Property Rights means all industrial and intellectual property rights and interests of whatever nature throughout the world conferred under statute, common law or equity, whether existing now or at any time in the future, and includes rights in respect of or in connection with copyright, inventions (including patents), formulae, databases, business processes and methods, circuit layouts, plant varieties, trade marks, service marks, business names, trade names, domain names, designs, confidential information, trade secrets and know-how and similar industrial and intellectual property rights, whether or not registered or registrable, and includes the right to apply for or renew the registration of such rights.

65    The object of separating the definition of intellectual property assets into Additional IP and Business Intellectual Property appears to be to ensure that all intellectual property assets owned by Sargon Services (which may include assets outside those defined by the Court’s order of 1 May 2020) were sold pursuant to the Business Sale Agreement.

66    As can be seen, the definition of Business Intellectual Property makes express reference to the rights listed in Schedule 5 to the Business Sale Agreement. The assumption appears to be that those rights are owned by Sargon Services. Schedule 5 lists two items only: the domain name www.sargon.com and the Australian Business Name “Good Super”. The Schedule states that both are registered in the name of Sargon Services.

67    The latest balance sheet for Sargon Capital in evidence was dated 31 December 2019. The intangible asset account 1-2300 included two subsidiary accounts: 1-2305 (Intangible tech – Sargon) and 1-2375 (Intangible Other).

68    Subsidiary account 1-2305 (Intangible tech – Sargon) had a balance of $5,797,293.90 and included the following accounts:

69    Subsidiary account 1-2375 (Intangible Other) had a balance of $237,696.49 which was wholly made up of account 1-2320 (Domain Name).

70    The latest balance sheet for Sargon Services in evidence was also dated 31 December 2019. The intangible asset account 1-2300 included two subsidiary accounts: 1-2305 (Intangible tech - Sargon) and 1-2375 (Intangible Other).

71    Subsidiary account 1-2305 (Intangible tech – Sargon) had a balance of $1,037,554.95 and included the following accounts:

72    Subsidiary account 1-2375 (Intangible Other) had a balance of $11,695.72 which was wholly made up of account 1-2320 (Domain Name).

73    On 21 February 2020, Sargon Capital’s Managing Director, Mr Kingston, signed a Report on Company Activities and Property (ROCAP) of Sargon Capital as required by s 429(2) of the Corporations Act. The ROCAP contains a list of assets owned by Sargon Capital, and an estimated value of the assets, prepared by Mr Kingston. The list includes “Sargon Trustee Cloud (Software)” with an estimated value of $10 million and the domain name, www.sargon.com, with an estimated value of $237,696.49.

Submissions of the parties

74    Sargon Capital submitted that it is the owner of the trading and domain names listed in Schedule 8 of the Business Sale Agreement because it is the holder of the registration. While Sargon Services is the registrant of the Sargon domain name (www.sargon.com), Sargon Capital submitted that it was the beneficial owner. In support of that submission, it relied on:

(a)    the fact that, of the 28 domain names registered within the Sargon Group, 27 are registered to Sargon Capital;

(b)    the fact that Mr Kingston’s ROCAP also indicates that Sargon Capital held that domain name; and

(c)    an assertion that the asset is listed on Sargon Capital’s balance sheet.

75    Sargon Capital also submitted that, while Sargon Services is the registrant of the “Good Super” business name, Sargon Capital is the beneficial owner. In support, it asserted that the asset was listed on Sargon Capital’s balance sheet.

76    In respect of the software assets, Sargon Capital submitted that ownership should be recognised in accordance with the balance sheet accounts of Sargon Capital and Sargon Services.

77    Westpac acknowledged that Sargon Capital is the owner of the trading and domain names listed in Schedule 8 of the Business Sale Agreement (other than items 15, 16 and 33 to 35) because it is the holder of the registration. In relation to items 15, 16 and 33 to 35 (being various “Hong Kong trustee company” domain names), Westpac submitted that the evidence shows that no-one is recorded as the registrant of those domain names.

78    Westpac submitted that Sargon Services is the owner of the Sargon domain name (www.sargon.com) and the “Good Super” business name because it is the registrant. Westpac disputed that Sargon Capital’s balance sheet affords contrary evidence (as the balance sheet does not identify those specific assets).

79    In respect of the software assets, Westpac also submitted that ownership should be recognised in accordance with the balance sheet accounts of Sargon Capital and Sargon Services.

Consideration

80    Ultimately, there was no real dispute between the parties that ownership of the software assets should be recognised as being held by both Sargon Capital and Sargon Services, reflecting the fact that the balance sheets of both companies record (as an asset) capitalised expenditure on the software. While the relevant balance sheet accounts contain only a broad description of the software assets, they are the best evidence available to the Court as to the ownership of those assets. Based on those balance sheet accounts, as reproduced above, in my view the Sargon software systems (known as “Arcadia”, “Sentinel”, “Metropolis”, “API Impact”, and “Sargon Pay”) are owned in part by Sargon Capital and in part by Sargon Services, as reflected in:

(a)    the Sargon Capital account 1-2305 (Intangible tech – Sargon) and its subsidiary accounts: 1-2350 (Software API 0.1), 1-2355 (Amortisation of API 1.0), 1-2360 (Software API 1.0), 1-2380 (Sargon Technology) and 1-2385 (Amortisation of Sargon Technology); and

(b)    the Sargon Services subsidiary account 1-2380 (Sargon Technology).

81    The Sargon website software is owned by Sargon Services, as reflected in its balance sheet subsidiary accounts 1-2310 (Website) and 1-2315 (Amortisation of Website).

82    I find that the trade marks and domain names listed in Schedule 8 to the Business Sale Agreement are owned by Sargon Capital, as the available evidence suggests that it is the registrant of those trade marks and domain names. As to items 15, 16 and 33 to 35, the evidence relied on by Westpac does not establish that Sargon Capital was not the registrant of those names; the evidence only established that searches had failed to reveal the registrant of those names. In circumstances where Sargon Services executed the Business Sale Agreement implicitly recognising Sargon Capital as the owner of those names, and there being no contrary evidence, I find that Sargon Capital is the owner.

83    As to the domain name www.sargon.com and the business name “Good Super”, the parties acknowledge that they are registered in the name of Sargon Services. The matters relied on by Sargon Capital to establish that it is the beneficial owner of those names are not persuasive. The fact that other trading and domain names are registered to Sargon Capital is entirely neutral. The balance sheets of Sargon Capital and Sargon Services do not provide a definitive answer because each has an asset account designated 1-2320 (Domain Names), and there is no evidence as to the domain names included within the account. While Mr Kingston’s ROCAP lists the Sargon domain name as an asset of Sargon Capital, I do not regard the ROCAP as a reliable source of information. Mr Kingston did not give evidence and accordingly there is no evidence as to the basis on which Mr Kingston included that asset as an asset of Sargon Capital. The value attributed to the asset in the ROCAP is the same as the value recorded in the Sargon Capital balance sheet in respect of the account 1-2320 (Domain Names), which suggests that Mr Kingston assumed that that account related to the Sargon domain name. In the absence of other evidence, I find that Sargon Services, as registrant, is the owner of the domain name www.sargon.com and the business name “Good Super”.

G.2    GrowthOps’ claims to the Developed IP

Overview

84    As already noted, questions 3.4 to 3.6 focus on GrowthOps’ claims to ownership of the Developed IP. The questions can be paraphrased as whether the Developed IP was sold as part of the Cloverhill Sale (including as part of the Sargon software systems) so as to generate part of the Retained Proceeds and whether GrowthOps was the owner of the Developed IP at the time of sale such that it is entitled to a proportion of the Retained Proceeds. The latter question requires consideration of whether clause 7.1 of each of the Technology MSA and the Marketing MSA is a security interest within the meaning of s 12 of the Personal Property Securities Act 2009 (Cth) (PPSA) and whether the interest (being unperfected) vested in Sargon Capital under s 267 of the PPSA upon the appointment of external administrators to Sargon Capital pursuant to s 436C of the Corporations Act on 8 March 2020.

Findings of fact

85    Mr McMenamin deposed that, between around 2018 and January 2020, GrowthOps and Sargon Capital entered into various contractual arrangements in which GrowthOps provided services (including software development services) to Sargon Capital. Those agreements included the Technology MSA and the Marketing MSA, the subject of GrowthOps’ claims.

The Technology MSA

86    GrowthOps and Sargon Capital were parties to the Technology MSA which commenced 1 July 2019.

87    Clause 3 of the agreement governed the services to be provided by GrowthOps pursuant to the agreement. Under that clause, GrowthOps agreed to provide Planning Services (as defined) in order to prepare a suitable Quarterly Growth Plan (as defined) for Sargon. The template Quarterly Growth Plan attached to the agreement indicated that the plans would define the scope of services to be provided and the fees payable. Sargon Capital could elect to proceed with a Quarterly Growth Plan or not proceed. If it proceeded with a Quarterly Growth Plan, Sargon Capital agreed to pay fees to GrowthOps for the services performed by the successful delivery of each agreed Scope (as defined). Clause 1.1 defined “Scope” as “each and any subset of agreed services to be performed by GrowthOps for Sargon pursuant to a Quarterly Growth Plan, detailing certain outcomes, Deliverables and Fees payable as against (draw down against) the Quarterly Growth Budget in accordance with Schedule B”. “Deliverables” were defined as the deliverables provided to Sargon Capital by GrowthOps as set out in accordance with a Scope and/or Quarterly Growth Plan, which may include software.

88    Clause 7.1 of the Technology MSA relevantly provided as follows:

7.1 Intellectual Property Rights

(a)     All Intellectual Property Rights in the Services and Deliverables (Developed IP), except any GrowthOps Background IP or its service methodology and knowledge, vests in Sargon immediately upon payment to GrowthOps for same, and GrowthOps hereby assigns, and must procure that its personnel assign, all Intellectual Property Rights in the Developed IP To [sic] Sargon. GrowthOps agrees to do all things which may be necessary for these ownership rights to pass to Sargon. At Sargon’s request, GrowthOps must provide, and ensure that its personnel or sub-contractors provide consents to or waivers of any moral rights in specific Developed IP. This clause does not in any way derogate from the ability for GrowthOps to utilise the same service methodology for other clients.

(b)    GrowthOps agrees to provide Sargon with a statement of account on a quarterly basis demonstrating invoices paid and outstanding to date, whilst reflecting the vesting of ownership of Developed IP contemplated by 7.1(a).

…

89    Intellectual Property Rights was defined as:

…any rights in or to any patent, copyright (including rights in computer software), database rights, registered design or other design right, utility model, trade mark (whether registered or not and including any rights in get up or trade dress), brand name, logo, service mark, trade or business name, domain name, eligible layout right, chip topography right and any other rights of a proprietary nature in or to the results of intellectual activity in the industrial, commercial, scientific, literary or artistic fields, whether registrable or not and wherever existing in the world, including all registrations, applications, renewals, extensions, continuations, divisions and reissuances associated with, and all rights to apply for, any such rights.

90    Mr McMenamin deposed that GrowthOps prepared two Quarterly Growth Plans under the Technology MSA. The first was for the quarter commencing 1 July 2019 and the second was for the quarter commencing 1 October 2019. Copies were in evidence. Each was a detailed document describing the “Scopes”, being software improvements or modifications to Sargon’s software systems. Each Scope specified a timeframe for delivery and the fee payable. GrowthOps provided the Court with an aide memoire linking each item in the Scopes with particular Sargon software systems (Arcadia, Sentinel, Metropolis, API Impact and Pay). The aide memoire was not the subject of dispute by any party.

91    Mr McMenamin deposed that the following invoices were issued by GrowthOps to Sargon Capital under the Technology MSA:

92    The aggregate value of the above invoices (excl GST), $1,509,083.85, is materially the same as the amount by which the subsidiary account 1-2380 (Sargon Technology) in the Sargon Capital balance sheet increased in value from June 2019 (at which time it was valued at $5,153,947.00) to December 2019 (at which time it was valued at $6,663,030.82).

93    In the above table, and in what follows, I have referred to the amounts invoiced by GrowthOps to Sargon Capital exclusive of GST. The reason for using the GST exclusive figures is that the task is to determine GrowthOps’ proportionate ownership interest in the intellectual property assets sold under the Business Sale Agreement. The proportionate ownership interest must be based on the asset value and that part of the asset value that should be regarded as being owned by GrowthOps. The expenditure on the development of the software assets was capitalised in the balance sheets of Sargon Capital and Sargon Services, but only in respect of the GST exclusive amounts (no doubt because the GST payments made by Sargon Capital in respect of the development of the software would have been offset against GST payments received by Sargon Capital for tax purposes). The use of GST exclusive figures is consistent with the evidence of Mr McMenamin and the valuation methodology adopted by Mr Hall (and neither Mr Samuel nor Mr Jaski suggested otherwise). Conversely, the task is not to determine how much GrowthOps is owed as an unpaid creditor (which would include the unpaid amounts of the invoices, including GST, as well as interest due on unpaid amounts).

94    In its written submissions and aides memoire provided to the Court, GrowthOps did not press any claim in respect of the first four invoices being INV/GOS/00112, INV/GOS/00072, INV/GOS/00113 and INV/GOS/00094. GrowthOps’ claim in respect of services provided under the Technology MSA was confined to invoices INV/GOS/00110, INV/GOS/00129 and INV/GOS/00142 which totalled $980,955.35 (excl GST). In relation to invoices INV/GOS/00072 and INV/GOS/00094, Mr McMenamin deposed that the invoices had been paid by Sargon Capital. Accordingly, no claim was made for those amounts. However, no clear explanation was provided in the evidence or submissions in relation to invoices INV/GOS/00112 or INV/GOS/00113. The notations on those invoices indicate that they relate to consulting fees provided by GrowthOps, and the amounts invoiced were deducted from INV/GOS/00072 and INV/GOS/00094 respectively. I can only infer from the fact that no claim was pressed by GrowthOps in respect of those invoices and the notation on those invoices that they did not relate to the development of software but other consultancy services (despite the coincidence between the (GST exclusive) gross value of the invoices and the increase in the “Sargon Technology” asset in the Sargon Capital balance sheet between June 2019 and December 2020).

95    GrowthOps provided the Court with an aide memoire linking invoices INV/GOS/00110, INV/GOS/00129 and INV/GOS/00142 with the Quarterly Growth Plans and each delivered Scope. Again, the aide memoire was not the subject of dispute by any party.

96    Ultimately, there was no dispute concerning the fact that the work performed by GrowthOps pursuant to the Technology MSA, and invoiced under invoices INV/GOS/00110, INV/GOS/00129 and INV/GOS/00142, involved software improvements or modifications to Sargon’s software systems as identified above. Nor was there any dispute that the invoices were unpaid.

97    I therefore find that the value of the Sargon software systems recorded in the Sargon Capital balance sheet as at 31 December 2019 included the (GST exclusive) cost of software development performed by GrowthOps under the Technology MSA as reflected in invoices INV/GOS/00110, INV/GOS/00129 and INV/GOS/00142, being an amount of $980,955.35.

The Marketing MSA

98    GrowthOps and Sargon Capital were also parties to the Marketing MSA which had a commencement date of 2 September 2019.

99    Under clause 3.1 of the Marketing MSA, GrowthOps agreed to provide Sargon Capital with (a) Retainer Services (as defined) and (b) Project Services (as defined) as required by Sargon Services throughout the term of the agreement. Retainer Services were defined (by reference to Item 1A of Schedule B) as follows (together with incidental services):

The following services will be performed by GrowthOps in exchange for the Retainer Fees:

• Creative

• Marketing

• Coaching / Leadership

• Marketing advice in relation to the Max Super Fund

100    The Retainer Fees were defined (by reference to Item 1B of Schedule B) as $500,000 per month from the commencement date until expiry of the sixth calendar month and $350,000 per month from the seventh calendar month until the expiry date.

101    The Project Services were defined as services specified by Sargon Capital in a Project Brief and an Approved Quotation under clause 3.2 (together with incidental services). Clause 3.2 stipulated that, if Sargon Capital required Project Services, it would provide a Project Brief to GrowthOps which would specify the scope of the services and GrowthOps would provide a quote for the Project Services. Under clause 3.3, Sargon Capital agreed to pay fees in relation to services performed by GrowthOps pursuant to the successful delivery by GrowthOps of each agreed Statement of Works and/or Project Brief (applicable to the relevant service) during the Term. Schedule D contained a pro forma Statement of Works. Although not stated expressly in the agreement, it is implicit that Project Services to be provided by GrowthOps to Sargon Services would be detailed in a Statement of Works.

102    Clause 5 governed the fees, invoicing and payment for the Retainer Services and Project Services.

103    Clause 7 (Intellection Property) and clause 9.2 (Consequences of Termination) were in identical terms to those clauses in the Technology MSA (reproduced above).

104    Mr McMenamin deposed that GrowthOps issued 11 Statements of Works under the Marketing MSA between September 2019 and December 2019. Copies of the Statements of Works were in evidence. They specified a range of services to be provided by GrowthOps concerning marketing strategies, some of which related to online marketing activities. The services included various search engine optimisation services; quantitative market research including consumer surveys; image strategy; design of marketing flyers and brochures; review of brand and product position; communications strategy; and other marketing-related activities.

105    Mr McMenamin also deposed that 17 invoices were issued by GrowthOps to Sargon Capital under the Marketing MSA between 30 September 2019 and 31 January 2020. In its written submissions and aides memoire provided to the Court, GrowthOps only pressed its claim in respect of 15 of those invoices (it excluded INV/GOS/00146 and INV/GOS/150) which it submitted related to the Statements of Works under the Marketing MSA. The 15 invoices totalled $131,819 (excl GST). GrowthOps provided the Court with an aide memoire linking relevant invoices with the Statements of Work under the Marketing MSA.

106    Ultimately, there was no dispute concerning the fact that the work performed by GrowthOps pursuant to the Marketing MSA was the work defined by the Statements of Work. Nor was there any dispute as to the value of unpaid invoices in respect of that work.

Was the Developed IP sold as part of the Cloverhill Sale (including as part of the Sargon software systems) so as to generate part of the Retained Proceeds?

107    GrowthOps submitted that, in the course of performing services for Sargon Capital pursuant to the Technology MSA and the Marketing MSA, GrowthOps developed software and other items in which intellectual property (copyright) subsists. It further submitted that the intellectual property comprised a key asset that was sold under the Business Sale Agreement. In relation to the work performed under the Technology MSA, GrowthOps submitted that it developed software improvements to Sargon’s software systems, as evidenced by the Quarterly Growth Plans and Scopes. In relation to the work performed under the Marketing MSA, GrowthOps submitted that it produced “deliverables” as described in the Statements of Works and that it may be inferred that the deliverables were sufficiently connected with the creation of intellectual property rights because the invoices relating to the “deliverables” were capitalised on the balance sheet of Sargon Capital. In that regard, GrowthOps argued that the value of the “Sargon Technology” asset in the Sargon Capital balance sheet increased in value from June 2019 to December 2019 by $1,509,083.85 and that the GST inclusive value of the invoices issued by it under the Technology MSA and the Marketing MSA, for which it made a claim, totalled $1,569,593.13.

108    Westpac acknowledged that the Developed IP, so far as it comprised part of the Sargon software systems, was sold as part of the Cloverhill Sale and generated part of the Retained Proceeds. In relation to any Developed IP that was created under the Marketing MSA, Westpac submitted that it did not generate any part of the Retained Proceeds. Westpac argued that the invoices issued under the Marketing MSA were of relatively modest value and related to marketing services, not software development, and that the evidence did not show that the services resulted in the creation of any intellectual property, let alone intellectual property that had value in the context of the Cloverhill Sale.

109    I am satisfied on the evidence that, under the Technology MSA, GrowthOps developed software modifications or additions to the Sargon software systems that were sold as part of the Cloverhill Sale so as to generate part of the Retained Proceeds. The developed software was a literary work within the meaning of the Copyright Act 1958 (Cth). A literary work is defined in s 10 of the Copyright Act 1958 (Cth) as including “a computer program or compilation of computer programs”. A computer program is defined in s 47AB to include any literary work that is (a) incorporated in, or associated with, a computer program; and (b) essential to the effective operation of a function of that computer program. Ownership of a literary work vests in the author: see s 35(2) of the Copyright Act 1958 (Cth). Subject to exceptions that are not presently relevant, where the literary work is made by the author in pursuance of the terms of his or her employment, the employer is the owner of the copyright: see s 35(6) of the Copyright Act 1958 (Cth). Westpac submitted that there is no evidence that the software developed pursuant to the Technology MSA was authored by employees of GrowthOps. In the absence of any evidence suggesting that GrowthOps sub-contracted the work under the Technology MSA, I infer that the software was authored by employees of GrowthOps.

110    As set out earlier, the Sargon software systems that were sold as part of the Cloverhill Sale were recorded as assets in the following accounts in the balance sheets of Sargon Capital and Sargon Services: the Sargon Capital account 1-2305 (Intangible tech – Sargon) and its subsidiary accounts and the Sargon Services subsidiary account 1-2380 (Sargon Technology). The software development undertaken by GrowthOps was done for Sargon Capital. As explained above, the (GST exclusive) amounts invoiced by GrowthOps to Sargon Capital under the Technology MSA were capitalised on Sargon Capital’s balance sheet in the subsidiary account 1-2380 (Sargon Technology). It follows that part of the value of the Sargon Capital account 1-2305 (Intangible tech – Sargon) is attributable to the software development performed by GrowthOps under the Technology MSA in the amount of $980,955.35.

111    Conversely, I am not satisfied on the evidence that, under the Marketing MSA, GrowthOps developed intellectual property that was sold as part of the Cloverhill Sale so as to generate part of the Retained Proceeds. The Statements of Works under the Marketing MSA do not support a conclusion that the works included software development (whether relating to the Sargon software systems or the Sargon website) or the development and registration of trading and domain names. Rather, the Statements of Works indicate that the services related to marketing activities. It may be that, in the course of providing those services, GrowthOps created literary or other works in which copyright subsisted. However, no such assets were identified in evidence. Nor were any such assets identified by reference to the balance sheets of Sargon Services or Sargon Capital. While the Business Sale Agreement transferred all intellectual property used or in the possession of Sargon Services (based on the Court’s order of 1 May 2020), there is no evidence to support a finding that any copyright work created by GrowthOps under the Marketing MSA was considered by Sargon Services or Pacific Infrastructure to have value in the context of the sale.

Was GrowthOps the owner of the Developed IP at the time of sale such that it is entitled to a proportion of the Retained Proceeds?

112    The dispute between the parties with respect to ownership of the Developed IP focused on the meaning and effect of clause 7.1(a) of each of the Technology MSA and the Marketing MSA in light of s 267 of the PPSA. As I have found that only the Developed IP under the Technology MSA was sold as part of the Cloverhill Sale so as to generate part of the Retained Proceeds, the remainder of this section focusses on the Technology MSA. However, the same reasoning would apply to the Marketing MSA.

113    It is convenient to reproduce clause 7.1(a) of the Technology MSA:

All Intellectual Property Rights in the Services and Deliverables (Developed IP), except any GrowthOps Background IP or its service methodology and knowledge, vests in Sargon immediately upon payment to GrowthOps for same, and GrowthOps hereby assigns, and must procure that its personnel assign, all Intellectual Property Rights in the Developed IP To [sic] Sargon. GrowthOps agrees to do all things which may be necessary for these ownership rights to pass to Sargon. At Sargon’s request, GrowthOps must provide, and ensure that its personnel or sub-contractors provide consents to or waivers of any moral rights in specific Developed IP. This clause does not in any way derogate from the ability for GrowthOps to utilise the same service methodology for other clients.

114    Westpac and Sargon Capital contend, among other things, that the effect of clause 7.1(a) was to grant a security interest over the Developed IP in favour of GrowthOps (being a retention of title clause) within the meaning of s 12 of the PPSA. They argued that the security interest was not perfected by GrowthOps (the interest was not registered under the PPSA) and that, by virtue of s 267 of the PPSA, the security interest vested in Sargon Capital.

115    Section 12 of the PPSA relevantly provides as follows:

(1)    A security interest means an interest in personal property provided for by a transaction that, in substance, secures payment or performance of an obligation (without regard to the form of the transaction or the identity of the person who has title to the property).

(2)     For example, a security interest includes an interest in personal property provided by any of the following transactions, if the transaction, in substance, secure payment or performance of an obligation:

…

(d)    a conditional sale agreement (including an agreement to sell subject to retention of title);

...

(5)    A security interest does not include:

(a)     a licence; or

(b)     an interest of a kind prescribed by the regulations for the purposes of this section.

116    Section 267(1) of the PPSA provides that the section applies if, relevantly:

(a)    an administrator of a company is appointed (whether under ss 436A, 436B or 436C of the Corporations Act); and

(b)    a security interest granted by the company is unperfected at a time when, on a day, the event occurs by virtue of which the day is the section 513C day for the company within the meaning of the Corporations Act.

117    Section 267(2) of the PPSA provides as follows:

The security interest held by the secured party vests in the grantor immediately before the event mentioned in paragraph (1)(a) occurs.

118    An administrator was appointed to Sargon Capital on 8 March 2020, prior to it being wound up. Accordingly, the section 513C day for Sargon Capital is 8 March 2020. There was no dispute between the parties that, if clause 7.1(a) conferred a security interest on GrowthOps, that security interest was unperfected as at 8 March 2020. GrowthOps did not have possession or control over the Developed IP as the software had been made available to Sargon Capital (on GrowthOps’ admission, pursuant to an implied licence) and the security interest had not been registered by GrowthOps (see s 21 of the PPSA). Thus, the relevant question is whether clause 7.1(a) conferred a security interest.

119    GrowthOps submitted that, under clause 7.1(a), GrowthOps owned the Developed IP on its creation and agreed to transfer ownership to Sargon Capital after GrowthOps had completed providing all the services to Sargon Capital under the agreement and Sargon Capital had paid all of the fees relating to those services. Despite that, GrowthOps contended that clause 7.1(a) did not create a security interest within the meaning of s 12 of the PPSA. In support of that contention, it advanced the following submissions.

120    First, it submitted that, pending payment of the fees due, there was an implied licence for Sargon Capital to use the Developed IP. GrowthOps submitted that, in circumstances where ownership of the Developed IP had not been transferred but Sargon Capital was permitted to use the Developed IP, it was necessary to imply a licence to govern the relationship: BP Refinery (Westernport) Pty Ltd v Hastings Shire (1994) 180 CLR 266. It argued that a security interest under the PPSA does not include a licence (see s 12(5)(a) of the PPSA).

121    The first submission is misconceived. Assuming there was an implied licence between GrowthOps and Sargon Capital, and accepting that the implied licence is not a security interest within the PPSA, the argument does not address the relevant question. The asset sold as part of the Business Sale Agreement was not the implied licence. The relevant asset is the copyright in the Developed IP. The relevant question is whether the Technology MSA was an agreement to sell the copyright in the Developed IP subject to retention of title within the meaning of s 12(2)(d) of the PPSA.

122    Second, GrowthOps submitted that the rights and entitlements of GrowthOps under the Technology MSA do not amount to a security interest at general law, relying on Dura (Australia) Constructions Pty Ltd v Hue Boutique Living Pty Ltd (2014) 49 VR 86 (Dura Constructions) at [37]. The submission was not developed in writing or orally.

123    The second submission is also misconceived. In Dura Constructions, the relevant question was whether the alleged security interest was a charge within the meaning of s 12 of the PPSA. Santamaria JA (with whom the other members of the Victorian Court of Appeal agreed), reasoned that that question should be answered by ascertaining “from the language which the parties have used the nature of the rights and obligations which they intended to create” and then to consider whether, as a matter of law, those rights and obligations give rise to a charge (within the meaning of the PPSA) (at [37]). The relevant issue remains construction of the statute, albeit the statute may use terms that have well-defined meanings at law.

124    Third, GrowthOps submitted that s 3 of the PPSA recognises that personal property includes many different kinds of tangible and intangible property. Goods are defined in s 10 of the PPSA as personal property that is tangible property. While copyright is personal property (see s 196 of the Copyright Act 1968 (Cth) (Copyright Act)), it is intangible property and, therefore, is not a “good” for the purposes of the PPSA. GrowthOps submitted that the expression “conditional sale agreement” in s 12(2)(d) is implicitly confined to goods and therefore did not apply to the Developed IP (which is copyright). In support of the submission, GrowthOps argued that such a limitation to s 12(2)(d) is implicit because it sits in a list of expressions (in s 12(2)) which can only relate to goods. It further argued that the expression “conditional sale agreement” is familiar in the context of a sale of goods and, in s 6 of the Goods Act 1958 (Vic), there is a reference to a sale of goods being conditional or unconditional. Further, s 19(5) of the PPSA refers to a conditional sale agreement of goods.

125    I reject the third submission. None of the arguments advanced by GrowthOps affords any basis for reading down the plain meaning of the text of s 12(2)(d) of the PPSA such that it only applies to goods. It can be accepted that copyright is personal property that is intangible and, therefore, is not a “good” for the purposes of the PPSA. However, as acknowledged by GrowthOps, the PPSA applies to personal property whether it is tangible or intangible. There is no reason in law why a retention of title clause can only relate to personal property that is tangible. There is no contextual or purposive reason to exclude intangible property from the reach of the expression. The Goods Act 1958 (Vic) is wholly irrelevant and s 19 of the PPSA addresses a separate question of when the security interest attaches to the collateral. Many of the examples of security interests listed in s 12(2) are capable of applying to personal property that is intangible. Furthermore, the structure of s 12 is that the primary definition of “security interest” appears in s 12(1) which refers generally to “an interest in personal property provided for by a transaction that, in substance, secures payment or performance of an obligation”. The primary definition is applicable to personal property and draws no distinction between tangible and intangible property. The examples of security interests listed in s 12(2) are listed inclusively and are not stated to be exhaustive of the security interests in s 12(1). The fact that some of the examples in s 12(2) may only be applicable to goods does not support a conclusion that other examples should be implicitly limited to goods. GrowthOps was unable to advance any reason why the purposes of the PPSA would be advanced by its construction of s 12(2)(d).

126    In my view, the purposes of the PPSA would be undermined by the limitation sought to be imposed by GrowthOps on s 12(2)(d). The Outline to the Explanatory Memorandum that accompanied the enactment of the PPSA states (at p 10) that the purpose of introducing the PPSA was to achieve “more certain, consistent, simpler and cheaper arrangements for personal property securities.” The Outline explains that the legislation takes a functional approach to the determination of a security interest. As the Court of Appeal for British Columbia said in 674921 BC Ltd v Advanced Wing Technologies Corp (2006) 9 PPSA (d) 43; 263 DLR (4th) 290 at [1] in respect of the equivalent Canadian law, the statutory scheme:

“swept away various statutory, common law and equitable rules dealing with secured transactions involving personal property… This patchwork of rules relating to constructive and actual knowledge, title, registration, crystallization, realization and priorities had developed over many years in response to changing exigencies and without any overall rationale. The new unified statutory scheme (‘PPSA’) applies to all interests that ‘in substance’ create security interests on personal property.

127    It is well established that jurisprudence developed abroad remains important to the interpretation of the PPSA domestically, as the PPSA was modelled on New Zealand, Canadian and United States legislation: see e.g. Re Maiden Civil (P&E) Pty Ltd; Albarran v Queensland Excavation Services Pty Ltd [2013] NSWSC 852; 277 FLR 337 at [32].

128    Fourth, GrowthOps submitted that, on the proper construction of the Technology MSA, there was no conditional sale agreement because there was no “sale”. Rather, there was a provision of services for a fee, incidental to which there was creation of intellectual property which was transferred upon payment of the fee.

129    I reject that submission. It can be accepted that, at the time the Technology MSA was entered into, the Developed IP did not then exist. The agreement was for the provision of services to develop improvements or additions to the Sargon software, and the software was developed over time. However, the terms of the Technology MSA expressly contemplated that, once the software was developed pursuant to the agreement, ownership would vest in Sargon Capital upon payment of all fees owing to GrowthOps. Clause 3.3(a) of the agreement stipulated that Sargon Capital agreed to pay fees for each agreed Scope “including any Services and Deliverables detailed in a Scope”. The expression “Deliverables” was defined to include software. Clause 7.1(a) stipulated that all intellectual property rights in the Services and the Deliverables vests in Sargon Capital upon payment. Thus, the Technology MSA was an agreement both for the provision of services (which included the development of software) and the sale of the developed software to Sargon Capital. It is artificial to characterise the agreement as only an agreement for the provision of services; the sale of the developed software was an integral part of the agreement.

130    Fifth, GrowthOps submitted that, on the proper construction of clause 7.1(a), there was no transaction that, in substance, secured payment or performance of an obligation. GrowthOps argued that clause 7.1(a) did not ‘secure’ payment of the fees but merely spelled out the time for title in the Developed IP to pass to Sargon Capital. Unlike clause 5.4(c), which provided for the charging of interest and suspension of performance of services if the fees were unpaid, clause 7.1(a) did not create an incentive for Sargon Capital to pay the fees or a disincentive to delay or to avoid payment. That is because, even if the fees remained unpaid, Sargon Capital nevertheless continued to enjoy the use of the Developed IP through the implied licence.

131    I reject that submission. Any implied licence granted by GrowthOps to Sargon Capital to use the Developed IP pending contractual payments did not remove the incentive, created by clause 7.1(a), to pay for the Developed IP. That is because any implied licence, required to give business efficacy to the agreement, would only constitute a licence until termination of the agreement. Under clause 9.1 of the agreement, a party was entitled to terminate the agreement upon default by the other party which is not remedied within 90 days of a demand being made. If payments were not made by Sargon Capital following demand for payment and GrowthOps elected to terminate the agreement, it would follow that any implied licence would be at an end and Sargon Capital would be required to cease using the Developed IP (for which it had not paid). It follows that clause 7.1(a) secured payment of the fees because Sargon Capital would not become entitled to use the Developed IP on a permanent basis unless it paid the fees owing.

132    In my view, clause 7.1(a) is properly characterised as a retention of title clause and created a security interest within the meaning of s 12 of the PPSA. The clause related to software that would be created under the agreement. As discussed above, copyright subsists in software and the copyright is personal property (s 196 of the Copyright Act). The clause effected an assignment of such future created copyright in compliance with the requirements of s 197 of the Copyright Act, but the assignment was conditional. The copyright would not vest in Sargon Capital until payment was made by Sargon Capital. Such an arrangement is a textbook example of a retention of title clause: Aluminium Industrie Vaassen BV v Romalpa Aluminium Ltd [1976] 1 WLR 676. Clause 7.1(a) was designed to protect GrowthOps from the consequences of Sargon Capital’s insolvency by the simple expedient of providing that GrowthOps would retain title in the Developed IP until it was paid for: Armour v Thyssen Edelstahlwerke AG [1991] 2 AC 339 at 352-3. This very proceeding, by which GrowthOps is seeking to have its retained ownership interest in the Developed IP recognised by the Court in circumstances where Sargon Capital has become insolvent and has not paid for the Developed IP demonstrates the function of clause 7.1(a).

133    It follows that, by the operation of s 267 of the PPSA, the security interest created by clause 7.1(a) (being the retained ownership of the Developed IP) vested in Sargon Capital immediately before 8 March 2020.

134    I note for completeness that Sargon Capital advanced an alternative argument that, on its proper construction, clause 7.1(a) effected an immediate assignment of copyright (upon its creation) to Sargon Capital (allowing it to use those rights as an assignee), whilst stipulating that the copyright would not vest in Sargon Capital until payment had been made (at which time the copyright would permanently vest in Sargon Capital). Sargon Capital argued that s 197 of the Copyright Act distinguishes between the “vesting” and “assignment” of copyright. It argued that the vesting of property carries with it a notion of permanency whereas an assignment may be limited or conditioned and is capable of being revoked or ended by the assignor.

135    I reject the alternative argument advanced by Sargon Capital. To the extent that there is a difference between the words “assign” and “vest” in the context of copyright, the word “assign” may be understood as the act of assigning the copyright and the word “vest” may be understood as the effect of the assignment. Under ss 196 and 197 of the Copyright Act, an assignment of existing and future copyright must be in writing signed by or on behalf of the assignee. Section 197(1) stipulates that (emphasis added):

Where, by an agreement made in relation to a future copyright and signed by or on behalf of the person who would, apart from this section, be the owner of the copyright on its coming into existence, that person purports to assign the future copyright (wholly or partially) to another person (in this subsection referred to as the assignee), then if, on the coming into existence of the copyright, the assignee or a person claiming under him or her would, apart from this subsection, be entitled as against all other persons to have the copyright vested in him or her (wholly or partially, as the case may be), the copyright, on its coming into existence, vests in the assignee or his or her successor in title by force of this subsection.

136    It can be seen that, in s 197(1), the words “assign” and “vest” have related meanings – the assignment results in vesting.

137    Section 196(2) of the Copyright Act provides that an assignment of copyright may be limited in any way, including temporally, geographically and by reference to the scope of the rights conferred. However, it does not follow that the word “vest” refers to the entirety of the copyright. Section 197(1) also contemplates that future copyright may be assigned wholly or partially and it is the rights assigned that “vest” in the assignee upon the copyright coming into existence.

138    Read in light of s 197 of the Copyright Act, in my view clause 7.1(a) constitutes an agreement by which GrowthOps assigned the whole of the future copyright in software created under the agreement to Sargon Capital, but on the condition that the copyright would not vest in Sargon Capital until it had paid for the software.

139    In conclusion, Sargon Capital, and not GrowthOps, was the owner of the Developed IP created under the Technology MSA at the time of the Cloverhill Sale.

G.3    Diversa’s claim to an equitable lien

140    Question 3.9 asks whether Diversa has a vendor's equitable lien over the shares of CCSL and DTL (which were sold as part of the Cloverhill Sale) to the extent that it has not been paid the purchase price for the sale of those shares to Sargon SH and Sargon SPV.

Findings of fact

141    By a Share Purchase Agreement dated 20 December 2018 between Diversa as vendor, OneVue as vendor guarantor, Sargon SH as purchaser and Sargon Capital as purchaser guarantor, Diversa agreed to sell to Sargon SH all of the shares in DTL and CCSL (Diversa SPA). The purchase price was $45 million, comprising an Initial Purchase Price of $37 million to be paid on the date of completion (subject to adjustment based on completion accounts to be prepared) and a further payment of a Deferred Purchase Price of $8 million. The payment of the Deferred Purchase Price was governed by clause 10.8 which stipulated that, subject to certain conditions being satisfied, Sargon SH was to pay the Deferred Purchase Price within 10 business days of the date that was 12 months after completion. The purchaser’s obligations under the Diversa SPA were guaranteed by Sargon Capital under clauses 22 which provided as follows:

22 Purchaser Guarantee and Indemnity

22.1 Guarantee

In consideration of the Vendor entering into this Agreement with the Purchaser at the request of the Purchaser Guarantor, the Purchaser Guarantor irrevocably and unconditionally guarantees to the Vendor the due and punctual performance of all present and future obligations and the payment of all present and future Liabilities of the Purchaser under this Agreement and must on demand by the Vendor perform those obligations or pay those Liabilities in the manner specified in this Agreement if the Purchaser fails to do so on the due date.

22.2 Indemnity

As a separate and independent obligation from that contained in clause 22.1, the Purchaser Guarantor indemnifies the Vendor against, and must pay to the Vendor on demand the amount of, any Liability suffered or incurred by the Vendor arising out of or in connection with any failure of the Purchaser to perform any obligation or pay any Liability under this Agreement on the due date.

22.3 Nature and preservation of liability

The Purchaser Guarantor acknowledges and agrees that each of its obligations under this clause 22:

(a)     is a principal and continuing obligation and will not be affected by any principle of law or equity which might otherwise reduce or limit in any way the liability of the Purchaser Guarantor under this clause 22; and

(b)     continues notwithstanding any amendment of this Agreement or any waiver, consent or notice given under this Agreement by any party to another.

22.4 Waiver of rights

The Purchaser Guarantor must not exercise any right of indemnity or subrogation which it might otherwise be entitled to claim and enforce against or in respect of the Purchaser and irrevocably waives all those rights of indemnity or subrogation it may have.

22.5 Restrictions on Purchaser Guarantor’s dealings

The Purchaser Guarantor irrevocably appoints the Vendor as its attorney to prove in the insolvency of the Purchaser for all money to which the Purchaser Guarantor may be entitled from the Purchaser up to an amount which does not exceed the amount which may be payable by the Purchaser Guarantor under this Agreement. The Purchaser Guarantor acknowledges that the Vendor may, subject to the terms of this Agreement, retain any money which the Vendor may receive from any proof on account of the Purchaser Guarantor’s liability under this clause 22.

142    Completion was originally due to occur on or before 31 March 2019, being the “Sunset Date” under the Diversa SPA (I note that the definition of Sunset Date in the agreement refers to 31 March 2018 rather than 31 March 2019, but that is an obvious typographical error given that the agreement was dated 20 December 2018).

143    On 29 March 2019, Diversa and Sargon SH agreed to vary the Diversa SPA by deferring the Sunset Date to 30 April 2019 (First SPA Variation). Sargon SH also agreed to pay $1 million into a bank account nominated by Diversa on the date of the agreement as a deposit towards the Initial Purchase Price. On completion, the Initial Purchase Price would be reduced by $1 million to reflect that deposit and the deposit would be retained by Diversa.

144    On 30 April 2019, Diversa and Sargon SH agreed to vary the Diversa SPA by deferring the Sunset Date by another month to 31 May 2019 (Second SPA Variation).

145    On 31 May 2019, Diversa and Sargon SH agreed to vary the Diversa SPA by deferring the Sunset Date to 21 June 2019 (Third SPA Variation). Sargon SH also agreed to pay a further deposit of $1 million into a bank account nominated by Diversa by 4 June 2019 as a deposit towards the Initial Purchase Price. On completion, the Initial Purchase Price would be reduced by the further amount of $1 million to reflect that deposit and the deposit would be retained by Diversa.

146    On 28 June 2019, each of the parties to the Diversa SPA as well as Sargon SPV (as a second purchaser) agreed to vary the Diversa SPA in a number of ways (Fourth SPA Variation). Relevantly, those parties agreed as follows:

(a)    Sargon SH agreed to purchase all of the 531,747 CCSL shares and 3,142,33 of the DTL shares and Sargon SPV agreed to purchase the balance of 2,000,000 DTL shares;

(b)    each reference to “Purchaser” in the Diversa SPA was amended to “Purchasers”, which was a reference to Sargon SH and Sargon SPV;

(c)    the completion date was set at 27 June 2019 (although completion did not in fact occur until the Fourth SPA Variation had been entered into on 28 June 2019);

(d)    the Initial Purchase Price was reduced to $12 million (from $37 million in the original Diversa SPA), with the parties acknowledging that $2 million had already been paid;

(e)    the Deferred Purchase Price was increased to $31 million (from $8 million) and would be due on 30 November 2019 (rather than the date falling 12 months after the completion date);

(f)    the total amount of the Initial Purchase Price and Deferred Purchase Price would be paid by Sargon SH and Sargon SPV on a pro rata basis determined by reference to the number of shares they were each acquiring; and

(g)    Clause 10.8 of the Diversa SPA (which concerned the Deferred Purchase Price) was amended to provide as follows:

(a)     Purchaser 1 and Purchaser 2 must pay their respective pro-rata allocation of the Deferred Purchase Price based on their Respective Number of Sale Shares to the Vendor on the Deferred Payment Date.

(b)     With effect from Completion and without prejudice to any other rights of the Purchasers under this Agreement, the Purchaser Guarantor assumes the obligations of Purchaser 1 and Purchaser 2 to pay the Deferred Purchase Price to the Vendor (but no other obligations) and following Completion:

(i)    the Vendor and Diversa Holdings will have no recourse to Purchaser 1 and Purchaser 2 in respect of the obligation to pay the Deferred Purchase Price; and

(ii)    the Vendor’s and Diversa Holdings’ sole recourse in respect of payment of the Deferred Purchase Price will be to the Purchaser Guarantor.

(c)     Notwithstanding any other provision of this Agreement, in the event that an “Event of Default” (as defined in the General Security Deed between SC Australian Holdings 1 Pty Ltd ACN 624 531 237 and the Vendor dated on or around the date of this Agreement) is subsisting, the Vendor may by notice to the Purchaser Guarantor declare that any part or all of the Deferred Purchase Price is due and payable on the date stated in the notice, such date not to be earlier than 2 Business Days from the date of that notice.

(d)     In the event that the Purchaser Guarantor fails to pay to the Vendor in cleared funds any part of the Deferred Purchase Price (Shortfall Amount) on the date which it is or becomes due and payable (Due Date), then the Purchaser Guarantor must pay to the Vendor on demand interest on the Shortfall Amount accruing daily at the rate of 12% per annum from the Due Date up to and including the date of payment.

(e)     A payment made pursuant to this Agreement with respect to the Shortfall Amount is to be treated as an increase of the Purchase Price.

147    Also on 28 June 2019, Diversa (as secured party) and SCAH1 (as grantor) entered into a General Security Deed (Diversa GSD). Under the Diversa GSD, SCAH1:

(a)    agreed to pay to Diversa the Secured Money (which was defined as the Deferred Purchase Price and any interest payable under the Diversa SPA) and indemnified Diversa in respect of Sargon Capital’s non-payment of the Secured Money as required under the Diversa SPA; and

(b)    granted to Diversa a security interest in the Collateral (defined broadly as all of SCAH1’s “rights, property and undertaking” whether “present or after-acquired”, including SCAH1’s shares in AdviceNet Pty Ltd, WealthPortal Pty Ltd, Madison Financial Group Pty Ltd and Pro Active Portfolios Pty Ltd) to secure payment of the Secured Money.

148    Clause 12.1 of the Diversa GSD stipulated that various events would be “Events of Default” including that Sargon Capital does not pay any part of the Secured Money or Sargon Capital or SACH1 become insolvent or an application is made to a court for their winding up or for the appointment of a receiver or liquidator.

149    Clause 19.9 of the Diversa GSD provided that the Diversa GSD did not merge with or adversely affect any Encumbrance (defined to include a mortgage, charge, pledge, lien or other security interest securing any obligation of any person or any other agreement or arrangement having a similar effect) or other right, power or remedy to which Diversa is entitled and that Diversa remained entitled to “exercise its rights, powers or remedies under [the GSD] as well as under the … other Encumbrance or the right, power or remedy”.

150    On the same day, 28 June 2019, completion under the Diversa SPA occurred. Diversa transferred the shares in DTL and CCSL to Sargon SH and Sargon SPV and Sargon SH and Sargon SPV paid to Diversa the remaining $10 million of the Initial Purchase Price.

151    On or about 22 November 2019, OneVue, Diversa, Sargon SH, Sargon SPV, Sargon Capital and SCAH1 agreed to vary the Diversa SPA (Fifth SPA Variation) and the Diversa GSD (First GSD Variation). Relevantly, those parties agreed as follows:

(a)    the date for payment of the Deferred Purchase Price (now the “Final Deferred Purchase Date”) would be 29 May 2020; and

(b)    clause 10.8 of the Diversa SPA was further amended to provide as follows:

(a)     Subject to clauses 10.8(b), (c) and (d), Purchaser 1 and Purchaser 2 must pay their respective pro-rata allocation of the Deferred Purchase Price based on their Respective Number of Sale Shares to the Vendor on the Final Deferred Payment Date.

(b)     In the event that prior to the Final Deferred Purchase Date the Purchaser Guarantor or any of its Subsidiaries completes any financing or fundraising transaction (including any debt, equity, convertible security, asset sale or other similar transaction or any drawdown under the TIM Facility which is not immediately applied in repayment of an Existing Debt Agreement (as defined below)) except for drawdowns of the TIM Facility for working capital purposes in respect of obligations or liabilities incurred after 20 November 2019 in the ordinary course of business (and excluding any payments to Affiliates of the Purchaser Guarantor), then to the extent that making such payment is not in breach of the terms of the existing debt agreements of the Purchaser Guarantor or any of its Subsidiaries as at 20 November 2019 (Existing Debt Agreements), the Purchaser Guarantor must pay to the Vendor within 5 Business Days of completion of such financing or fundraising transaction the amount by which the total funds raised exceed any amount which the Purchaser Guarantor or any of its Subsidiaries is legally obliged to repay as at that date under the terms of any Existing Debt Agreements which terms are in place as at 20 November 2019 (Free Cash Amount). Any such payments made to the Vendor under this clause 10.8(b) will be in part payment of the Deferred Purchase Price and the outstanding amount of the Deferred Purchase Price will be adjusted accordingly.

(c)    If:

(i)     Purchaser 1, Purchaser 2 or the Purchaser Guarantor becomes Insolvent; or

(ii)     an application is made to a court for an order to appoint a receiver, receiver and manager, provisional liquidator, liquidator, trustee for creditors or in bankruptcy or analogous person to Purchaser 1, Purchaser 2 or the Purchaser Guarantor or any of their respective assets, which application is not stayed, withdrawn or dismissed within 15 Business Days of being made, unless that application is frivolous or vexatious and is capable of being set aside,

the Deferred Purchase Price is immediately due and payable.

(d)    The Purchaser Guarantor agrees to transfer for no consideration all of its marketable securities (“SEQ Shares”) in Sequoia Financial Group Limited (ACN 097 744 884) (being 21,154,157 fully paid ordinary shares) to SC Australian Holdings 1 Pty Ltd (ACN 624 531 237) (“SC 1”) by 8 December 2019 and provide the Vendor with a copy of the holding statement or other reasonably satisfactory documentary evidence showing SC 1 as the holder of the SEQ Shares.

If the Purchaser Guarantor fails to comply with the obligation in the preceding paragraph, the Deferred Purchase Price shall be immediately due and payable on 9 December 2019.

(e)    With effect from Completion and without prejudice to any other rights of the Purchasers under this Agreement, the Purchaser Guarantor assumes the obligations of Purchaser 1 and Purchaser 2 to pay the Deferred Purchase Price to the Vendor (but no other obligations) and following Completion:

(i)    the Vendor and OneVue Holdings will have no recourse to Purchaser 1 and Purchaser 2 in respect of the obligation to pay the Deferred Purchase Price; and

(ii)    the Vendor’s and OneVue Holdings’ sole recourse in respect of payment of the Deferred Purchase Price will be to the Purchaser Guarantor.

(f)     Notwithstanding any other provision of this Agreement, in the event that an “Event of Default” (as defined in the General Security Deed between SC Australian Holdings 1 Pty Ltd ACN 624 531 237 and the Vendor dated on or around the date of this Agreement) is subsisting, the Vendor may by notice to the Purchaser Guarantor declare that any part or all of the Deferred Purchase Price is due and payable on the date stated in the notice, such date not to be earlier than 2 Business Days from the date of that notice.

(g)     In the event that the Purchaser Guarantor fails to pay to the Vendor in cleared funds any part of the Deferred Purchase Price (Shortfall Amount) on the date which it is or becomes due and payable (Due Date), then the Purchaser Guarantor must pay to the Vendor on demand interest on the Shortfall Amount accruing daily at the rate of 12% per annum from the Due Date up to and including the date of payment. The Purchaser Guarantor agrees to pay interest in cash on the outstanding balance of the Deferred Purchase Price at a rate of 8.0% p.a., payable monthly in arrears on the last day of each month. Interest will commence on the date of this deed and the first interest payment will be payable on 31 December 2019.

(h)     A payment made pursuant to this Agreement with respect to the Shortfall Amount is to be treated as an increase of the Purchase Price.

152    Under clause 10.8(d), the shares owned by Sargon Capital in Sequoia Financial Group Ltd were to be transferred to SCAH1 so that they would form part of the collateral over which Diversa had security by reason of the Diversa GSD. The Diversa GSD was also amended to include reference to those shares as part of the collateral.

153    As stated earlier, on 29 January 2020, Shaun Fraser and Jason Preston of McGrath Nicol were appointed as receivers and managers of Sargon Capital. On 31 January 2020, pursuant to cl 10.8(c) of the Diversa SPA (as amended), Diversa served on Sargon Capital a notice stating that the Deferred Purchase Price (as defined in the SPA) was immediately due and payable. On 10 February 2020, Diversa served a creditors’ statutory demand for payment on Sargon Capital, demanding payment of $31,261,935.28 (which included interest from 1 January 2020 to 6 February 2020). On 5 March 2020, Diversa lodged proofs of debt with the plaintiffs in their capacities as administrators of Sargon SH and Sargon SPV claiming:

(a)    the amount of $19,695,000 from Sargon SH; and

(b)    the amount of $11,567,000 from Sargon SPV.

Submissions of the parties

154    Diversa asserts a vendor’s equitable lien over the shares of CCSL and DTL, and the proceeds of their sale, to the extent of the unpaid purchase price (being the Deferred Purchase Price) and thereby makes claim to that proportion of the Retained Proceeds that is attributable to the shares in CCSL and DTL as a secured creditor of Sargon SH and Sargon SPV.

155    Diversa submitted that the lien arises by operation of law on the principle that “a person, having got the estate of another, shall not, as between them, keep it, and not pay the consideration”: Mackreth v Symmons (1808) 33 ER 778 (Mackreth) at 782 cited in Hewett v Court (1983) 149 CLR 639 (Hewett) at 645 (Gibbs CJ). The principle applies to a vendor’s lien over shares where the parties have agreed that the property is sold and transferred subject to payment of the purchase price (including by instalments): Langen & Wind Ltd v Bell [1972] Ch 685 (Langen) at 691-692 (Brightman J), referring to Albert Life Assurance Co, Ex parte Western Life Assurance Society (1870) LR 11 Eq 164 at 178 (Bacon V-C).

156    Diversa acknowledged that the lien may not arise where the agreement evinces a contrary intention or where the lien has been waived by the vendor (for example, where the vendor has agreed to alternative security being provided to it). In the present case, Diversa submitted that the Diversa SPA (as amended) did not show a contrary intention to the existence of the lien and there had been no waiver. The fact that Diversa agreed to take additional security from SCAH1 was not fatal to the lien, relying on Barclays Bank v Estates & Commercial Ltd [1997] 1 WLR 415 (Barclays Bank) at 421 (Millett LJ). Further, clause 19.9 of the Diversa GSD expressly maintained Diversa’s extant ‘encumbrances’, including liens. In relation to clause 10.8(b) as inserted in the Diversa SPA by the Fourth SPA Variation, Diversa argued that the clause did not extinguish the liability of Sargon SH and Sargon SPV to Diversa with respect to the Deferred Purchase Price but merely prevented recourse by Diversa against those entities. While the clause might prevent Diversa from bringing proceedings against either Sargon SH or Sargon SPV for the Deferred Purchase Price, it did not prevent Diversa from claiming in this proceeding an entitlement to the proceeds of an asset (the DTL and CCSL shares) over which Diversa has a lien. (While clause 10.8(b) of the Diversa SPA was renumbered 10.8(e) by the Fifth SPA Variation, I will refer to it as clause 10.8(b) because the time at which it was inserted into the Diversa SPA, by the Fourth SPA Variation, has some significance for the resolution of the issues.)